Renovare Environmental (RENO) 10-K 22 May 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	May 19, 2020	Jun. 28, 2019
Document and Entity Information
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Registrant Name	BIOHITECH GLOBAL, INC.
Entity Central Index Key	0001590383
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Trading Symbol	BHTG
Entity Common Stock, Shares Outstanding		17,437,288
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Public Float			$ 18.9

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue
Total revenue	$ 4,219,448	$ 3,359,324
Operating expenses
Selling, general and administrative	7,063,691	6,741,561
Depreciation and amortization	1,729,478	468,227
Total operating expenses	11,754,662	8,496,751
Loss from operations	(7,535,214)	(5,137,427)
Other (income) expenses
Gain on sale of affiliate investment	(562,617)	0
Equity loss in affiliate	0	601,927
Interest income	(69,930)	0
Interest expense	3,377,394	2,582,896
Expense incurred in warrant valuation and conversions		6,424,970
Total other (income) expenses	2,744,847	9,609,793
Net loss	(10,280,061)	(14,747,220)
Net loss attributable to non-controlling interests	(2,657,113)	(76,890)
Net loss attributable to Parent	(7,622,948)	(14,670,330)
Other comprehensive income (loss)
Foreign currency translation adjustment	(48,159)	43,611
Comprehensive loss	(7,671,107)	(14,626,719)
Net loss attributable to Parent	(7,622,948)	(14,670,330)
Preferred stock dividends	(721,987)	(492,639)
Deemed dividend on down round feature	(405,324)	0
Net loss attributable to- common shareholders	$ (8,750,259)	$ (15,162,969)
Net loss per common share - basic and diluted	$ (0.56)	$ (1.11)
Weighted average number of common shares outstanding - basic and diluted	15,668,679	13,616,268
HEBioT (related entity)
Revenue
Revenue	$ 1,111,071	$ 0
Operating expenses
Cost of revenue	2,064,139	0
Rental, service and maintenance [Member]
Revenue
Revenue	1,946,597	1,801,435
Operating expenses
Cost of revenue	784,291	884,342
Equipment sales [Member]
Revenue
Revenue	186,780	547,737
Operating expenses
Cost of revenue	113,063	402,621
Management advisory and other fees (related party) [Member]
Revenue
Revenue	$ 975,000	$ 1,010,152

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current Assets
Cash	$ 1,847,526	$ 2,410,709
Restricted cash	1,133,581	4,195,148
Accounts receivable, net (related entity $1,370,867 and $168,588 as of December 31, 2019 and 2018 respectively)	2,155,921	403,298
Inventory	467,784	499,848
Prepaid expenses and other current assets	126,357	66,425
Total Current Assets	5,731,169	7,575,428
Restricted cash	2,555,845	2,520,523
Equipment on operating leases, net	1,724,998	1,748,887
HEBioT facility, equipment, fixtures and vehicles, net	37,421,333	49,028
HEBioT facility under construction, net		33,104,007
Operating lease right of use assets	945,047
Investment in unconsolidated affiliates	0	1,687,383
MBT facility development and license costs	8,049,929	8,475,408
Goodwill	58,000	58,000
Other assets	53,726	97,433
Total Assets	56,540,047	55,316,097
Current Liabilities:
Line of credit, net of financing costs of $20,152 and $30,670 as of December 31, 2019 and 2018, respectively	1,479,848	1,469,330
Advance from related party	210,000	0
Accounts payable (related entity $2,531,034 and $160,761 as of December 31, 2019 and 2018, respectively)	4,688,339	1,310,998
Accrued interest payable	1,148,570	959,927
Accrued expenses and liabilities	1,926,965	3,354,124
Deferred revenue	89,736	98,596
Customer deposits	44,792	7,683
Note Payable	100,000
Current portion of WV EDA Senior Secured Bonds payable	1,390,000
Current portion of long term debt	4,605	9,165
Total Current Liabilities	11,082,855	7,209,823
Note payable	0	100,000
Junior note due to related party, net of unamortized discounts of $95,043 and $118,266 as of December 31, 2019 and 2018, respectively	949,434	926,211
Accrued interest (related party)	1,510,193	1,305,251
WV EDA Senior Secured Bonds payable, net of financing costs of $1,792,574 and $1,914,098 as of December 31, 2019 and 2018, respectively	29,817,426	31,085,902
Senior Secured Note, net of financing costs of $113,268 and $160,017 and unamortized discounts of $726,242 and $988,678, as of December 31, 2019 and 2018, respectively	4,160,490	3,851,305
Non-current lease liabilities	915,170
Long-term debt, net of current portion	8,201	12,806
Total Liabilities	48,443,769	44,491,298
Series A redeemable convertible preferred stock, 333,401 shares designated and issued, and 145,312 and 163,312 outstanding as of December 31, 2019 and 2018, respectively, net of current portion	726,553	816,553
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, Value, Issued
Common stock, $0.0001 par value, 50,000,000 shares authorized, 17,300,899 and 14,802,956 shares issued and outstanding as of December 31, 2019 and 2018, respectively	1,730	1,480
Additional paid in capital	49,597,059	43,452,963
Accumulated deficit	(52,785,242)	(44,594,385)
Accumulated other comprehensive income (loss)	(43,138)	5,021
Stockholders' equity attributable to Parent	2,024,143	3,405,551
Stockholders' equity attributable to non-controlling interests	5,345,582	6,602,695
Total Stockholders' Equity	7,369,725	10,008,246
Total Liabilities and Stockholders' Equity	56,540,047	55,316,097
Series B Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	0
Series C Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	3,050,142	3,050,142
Series D Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	1,505,262
Series E Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	$ 698,330	$ 1,490,330

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred stock, Designated shares	3,179,120	3,159,120
Preferred Stock, Shares Issued	1,922,603	1,922,603
Preferred Stock, Shares Outstanding		1,155,331
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	17,300,899	14,802,956
Common stock, shares outstanding	17,300,899	14,802,956
Debt Issuance Costs, Current, Net	$ 20,152	$ 30,670
Accounts Receivable, Related Parties, Current	1,370,867	168,588
Accounts Payable, Related Parties, Current	2,531,034	160,761
Junior Notes [Member]
Due to Related Parties, Noncurrent	95,043	118,266
Senior Notes [Member]
Debt Issuance Costs, Noncurrent, Net	113,268	160,017
Debt Instrument, Unamortized Discount, Noncurrent	726,242	988,678
WV EDA SENIOR NOTES [Member]
Debt Issuance Costs, Noncurrent, Net	$ 1,792,574	$ 1,914,098
Series A Redeemable Convertible Preferred [Member]
Preferred stock, Designated shares	333,401	333,401
Preferred Stock, Shares Issued	333,401	333,401
Preferred Stock, Shares Outstanding	145,312	163,312
Series B Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,111,200	1,111,200
Preferred Stock, Shares Issued	428,333	428,333
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,000,000	1,000,000
Preferred Stock, Shares Issued	427,500	427,500
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock [Member]
Preferred stock, Designated shares	20,000	20,000
Preferred Stock, Shares Issued	18,850	18,850
Preferred Stock, Shares Outstanding	18,850	18,850
Series E Convertible Preferred Stock [Member]
Preferred stock, Designated shares	714,519	714,519
Preferred Stock, Shares Issued	714,519	714,519
Preferred Stock, Shares Outstanding	264,519	564,519

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows used in operating activities:
Net loss	$ (10,280,061)	$ (14,747,220)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	1,729,478	468,228
Provision for bad debts	89,897	25,477
Share based employee compensation	1,099,567	836,372
Fees paid in stock and warrants	0	45,461
Interest resulting from amortization of financing costs and discounts	522,101	1,497,875
Gain on sale of affiliate investment	(562,617)	0
Equity loss in affiliate	0	601,927
Interest resulting from warrants valued upon conversion of host debt instruments	0	6,424,970
Warrants modification	49,160	0
Loss resulting from abandonment of MBT site	346,654	0
Changes in operating assets and liabilities	(128,779)	(1,197,234)
Net cash used in operating activities	(7,134,600)	(6,044,144)
Cash flows used in investing activities:
Construction in-progress and purchases of equipment, fixtures and vehicles	(5,111,209)	(329,575)
Cash acquired from control acquisition of Entsorga West Virginia, LLC	0	6,773,384
Proceeds from sale of investment in affiliate	2,250,000	0
MBT facility development costs incurred	(84,176)	(361,641)
MBT facility development costs refunded	66,000	0
Net cash provided by (used in) investing activities	(2,879,385)	6,082,168
Cash flows from financing activities:
Proceeds from common stock issuance, net of offering costs	3,035,557	0
Proceeds from issuance of senior secured credit facility and common stock	0	5,000,000
Repayment of line of credit facility	0	(2,463,736)
Proceeds from new line of credit facility	0	1,500,000
Exercise of employee stock options	0	61,977
Proceeds from the sale of Series D convertible preferred stock units	1,772,500	0
Payment of financing costs	(62,151)	(246,131)
Repayments of long-term debt	(9,165)	(8,875)
Proceeds from common stock issuance, net of offering costs	0	1,125,000
Investment in subsidiary by non-controlling interest	1,400,000	3,500,000
Redemption of Series A preferred stock	0	(317,000)
Advance from related party, net	210,000	0
Net cash provided by financing activities	6,346,741	8,151,235
Effect of exchange rate on cash	77,816	36,009
Net change in cash (restricted and unrestricted)	(3,589,428)	8,225,268
Cash - beginning of period (restricted and unrestricted)	9,126,380	901,112
Cash - end of period (restricted and unrestricted)	$ 5,536,952	$ 9,126,380

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member]Series A preferred stock [Member]	Preferred Stock [Member]Series B Preferred Stock [Member]	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series D Preferred Stock [Member]	Preferred Stock [Member]Series E Preferred Stock [Member]	Preferred Stock [Member]Series E Convertible Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member]Series A preferred stock [Member]	Common Stock [Member]Series B Preferred Stock [Member]	Common Stock [Member]Series C Preferred Stock [Member]	Common Stock [Member]Series D Preferred Stock [Member]	Common Stock [Member]Series E Preferred Stock [Member]	Common Stock [Member]Series E Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]Series A preferred stock [Member]	Additional Paid in Capital [Member]Series B Preferred Stock [Member]	Additional Paid in Capital [Member]Series C Preferred Stock [Member]	Additional Paid in Capital [Member]Series D Preferred Stock [Member]	Additional Paid in Capital [Member]Series E Preferred Stock [Member]	Additional Paid in Capital [Member]	Accumulated Comprehensive Other Loss [Member]Series A preferred stock [Member]	Accumulated Comprehensive Other Loss [Member]Series B Preferred Stock [Member]	Accumulated Comprehensive Other Loss [Member]Series C Preferred Stock [Member]	Accumulated Comprehensive Other Loss [Member]	Accumulated Deficit [Member]Series A preferred stock [Member]	Accumulated Deficit [Member]Series B Preferred Stock [Member]	Accumulated Deficit [Member]Series C Preferred Stock [Member]	Accumulated Deficit [Member]	Non-Controlling Equity Interest [Member]	Series A preferred stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Series E Preferred Stock [Member]	Total
Balance at Dec. 31, 2017							$ 699,332							$ 960						$ 17,752,990				$ (38,590)				$ (29,431,416)							$ (11,016,724)
Balance (in shares) at Dec. 31, 2017							160,000							9,598,208
Issuance of registered common shares, net of offering costs		$ 1,068,039	$ 3,050,142		$ 1,886,330				$ 0	$ 0		$ 0				$ 273,626	$ 1,360,681		$ 0			$ 0	$ 0			$ 0	$ 0				$ 1,341,665	$ 4,410,823		$ 1,886,330
Issuance of registered common shares, net of offering costs (in shares)		268,333	427,500		714,519
Issuance of preferred stock		$ 1,068,039	$ 3,050,142		$ 1,886,330				0	$ 0		0				273,626	$ 1,360,681		0			0	$ 0			0	$ 0				1,341,665	$ 4,410,823		1,886,330
Issuance of preferred stock (in shares)		268,333	427,500		714,519
Preferred Stock Conversion							$ 0							$ 330						9,090,045				0				0							9,090,375
Preferred stock dividends							0							0						407,061				0				(492,639)							(85,578)
Common stock issued for acquisition of Gold Medal Group							0							$ 50						2,249,950				0				0							2,250,000
Preferred Stock Conversion (in shares)														3,304,140
Common stock issued for acquisition of Gold Medal Group (in shares)														500,000
Share-based employee and director compensation							0							$ 0						836,372				0				0							836,372
Exercise of employee options							0							$ 2						61,975				0				0							61,977
Exercise of employee options (shares)														16,527
Share-based professional services compensation							0							$ 10						170,784				0				0							170,794
Share-based professional services compensation (in shares)														96,179
Conversion of debt into common stock							0							$ 330						9,090,045				0				0							9,090,375
Conversion of debt into common stock (in shares)														3,304,140
Interest on converted debt in common stock							0							$ 20						915,680				0				0							915,700
Interest on converted debt in common stock (in shares)														196,050
Conversion of preferred stock into common stock	$ 0	$ (428,333)			$ (1,767,371)	$ (396,000)		$ 11	$ 48				$ 15		$ 533,434	1,767,323			395,985		$ 0	$ 0			$ 0	$ 0				$ 533,445
Conversion of preferred stock into common stock (in shares)						(150,000)		118,542	480,067				150,000
Common stock issued in connection with debt financings							0							$ 32						1,212,089				0				0							1,212,121
Common stock issued in connection with debt financings (in shares)														320,000
Warrants valued in connection with debt conversions and amendments							0							$ 2						6,424,968				0				0							6,424,970
Warrants valued in connection with debt conversions and amendments (in shares)														23,243
Foreign currency translation adjustment							0							$ 0						0				43,611				0							43,611
Net loss							0							0						0				0				(14,670,330)							(14,670,330)
Net Loss																												0	$ (76,890)						(76,890)
Balance at Dec. 31, 2018																												(76,890)	6,679,585						6,602,695
Balance at Dec. 31, 2018							$ 4,540,472							$ 1,480						43,452,963				5,021				(44,594,385)							3,405,551
Equity interest of non-controlling equity holders of Entsorga West Virginia, LLC and Refuel America LLC and subsidiaries through December 13, 2018																												6,679,585	0						6,679,585
Balance (in shares) at Dec. 31, 2018							992,019							14,802,956
Issuance of registered common shares, net of offering costs				$ 1,505,262	$ (792,000)		$ 0				$ 0	$ 30		$ 188				$ 267,238	791,970	3,035,369													$ 1,772,500		3,035,557
Issuance of registered common shares, net of offering costs (in shares)				18,850	(300,000)							300,000		1,877,666
Issuance of preferred stock				$ 1,505,262	$ (792,000)		0				$ 0	$ 30		$ 188				$ 267,238	791,970	3,035,369													$ 1,772,500		3,035,557
Issuance of preferred stock (in shares)				18,850	(300,000)							300,000		1,877,666
Preferred stock dividends							0							$ (11)						(199,989)								162,585							(37,415)
Preferred stock dividends (in shares)														111,111
Share-based employee and director compensation							0							$ 8						1,099,559															1,099,567
Issuance of restricted stock		$ 0							$ 8							$ 205,492															$ 205,500
Issuance of restricted stock (shares)									75,000
Share-based professional services compensation (in shares)														84,166
Conversion of preferred stock into common stock	$ 0							$ 5							$ 89,995															$ 90,000
Conversion of preferred stock into common stock (in shares)								50,000
Foreign currency translation adjustment							0							$ 0						0				48,159											48,159
Warrant modification					$ 0							$ 0							$ 49,160															$ 49,160
Deemed dividend on down round feature							0							0						405,324								(405,324)
Net loss							0							0						0								(7,622,948)							(7,622,948)
Investment by non-controlling interest																													1,400,000						1,400,000
Net Loss																												(2,657,113)							(2,657,113)
Balance at Dec. 31, 2019																												(2,734,003)	$ 8,079,585						5,345,582
Balance at Dec. 31, 2019							$ 5,253,734							$ 1,730						$ 49,597,059				$ (43,138)				$ (52,785,242)							$ 2,024,143
Balance (in shares) at Dec. 31, 2019							710,869							17,300,899

Basis of Presentation and Going

Basis of Presentation and Going Concern	12 Months Ended
	Dec. 31, 2019
Basis Of Presentation And Going Concern
Basis of Presentation and Going Concern	Note 1. Basis of Presentation and Going Concern Nature of Operations - BioHiTech Global, Inc. (the “Company” or “BioHiTech”) through its wholly-owned and its controlled subsidiaries offers cost-effective and technologically innovative advancements integrating technological, biological and mechanical engineering solutions for the control, reduction and / or reuse of organic and municipal waste. As of December 31, 2019 and 2018, the Company’s active wholly-owned subsidiaries were BioHiTech America, LLC, BioHiTech Europe Limited, BHT Financial, LLC and E.N.A. Renewables LLC, and its controlled subsidiary was Refuel America LLC (60%) and its wholly-owned subsidiaries Apple Valley Waste Technologies Buyer, Inc., Apple Valley Waste Technologies, LLC, New Windsor Resource Recovery LLC and Rensselaer Resource Recovery LLC and its controlled subsidiary Entsorga West Virginia LLC (88.7% and 78.2% as of December 31, 2019 and 2018, respectively). Basis of Presentation - The accompanying consolidated financial statements include the accounts of the Company and its wholly owned and controlled subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions have been eliminated in consolidation. Under Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 280, segment reporting, the Company reports as a single segment company. Reclassifications to certain prior period amounts have been made to conform to current period presentation. These reclassifications have no effect on previously reported net loss. Going Concern and Liquidity - For the year ended December 31, 2019, the Company had a consolidated net loss of $10,280,061, incurred a consolidated loss from operations of $7,535,214 and used net cash in consolidated operating activities of $7,134,600. At December 31, 2019, consolidated total stockholders’ equity amounted to $7,369,725, consolidated stockholders’ equity attributable to parent amounted to $2,024,143 and the Company had a consolidated working capital deficit of $5,351,686. The Company does not yet have a history of financial profitability. Historically, the principal source of liquidity has been the issuance of debt and equity securities. Presently, the Company does not have firm commitments to fully fund its future operational and strategic plans, although subsequent to December 31, 2019 the Company raised $1,565,000 from the issuance of Series F Redeemable, Convertible Preferred Stock and warrants. The Company was funded $421,300 on May 13, 2020 through the Paycheck Protection Program (See Note 24) and has applied for an additional $200,000, which has not yet been approved. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management’s further implementation of the Company’s on-going and strategic plans, which include continuing to raise funds through equity and/or debt raises. Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification. The Company is presently in the process of raising additional debt for general operations and to support its leasing activities. The Company may also raise capital through its Registration Statement on Form S-3 declared effective on July 11, 2018, by the Securities and Exchange Commission (the “Shelf Registration”) for investment in several strategic initiatives. The Shelf Registration was utilized during September 2019 to raise net proceeds of $3,035,557 through a confidentially marketed public offering of common shares. There is no assurance that the Company will be able to raise sufficient capital or debt to sustain operations or to pursue other strategic initiatives or that such financing will be on terms that are favorable to the Company.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Use of Estimates — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, valuation of deferred tax assets, share based compensation, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including intangibles, and useful lives and other provisions and contingencies. Foreign Operations — Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates. Income and expense items are translated at the average rates during the respective periods. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of other comprehensive income (loss) while transaction gains and losses are recorded in net earnings (loss). Deferred taxes are not provided on cumulative foreign currency translation adjustments as the Company presently expects foreign earnings to be permanently reinvested. The Company pays Value Added Tax (“VAT”) or similar taxes (“input VAT”) within the normal course of its business in in the United Kingdom on merchandise and/or services it acquires. The Company also collects VAT or similar taxes on behalf of the government (“output VAT”) for merchandise and/or services it sells. If the output VAT exceeds the input VAT, then the difference is remitted to the government, usually on a monthly basis. If the input VAT exceeds the output VAT, this creates a VAT receivable. The Company either requests a refund of this VAT receivable or applies the balance to expected future VAT payables. Product and Services Revenue Recognition — The Company records revenue based on a five-step model in accordance with ASC 606, Revenue from Contracts with Customers, which require that we: 1. Identify the contract with a customer; 2. Identify the performance obligations in the contract; 3. Determine the transaction price of the contract; 4. Allocate the transaction price to the performance obligations in the contract; 5. Recognize revenue when the performance obligations are met or delivered. When revenue is earned based on product sales, such as sales of digester equipment and parts, solid recovered fuel and recycled materials, the Company’s performance obligations are satisfied at the point in time when products are shipped to the customer, which is when the customer has title and control. Therefore, the Company’s contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of products. When revenue is earned based on receipt of disposal waste, the Company’s performance obligations are satisfied at the point in time when disposal waste products are received from the customer, which is when the Company has title and control. Therefore, the Company’s contracts have a single performance obligation (receipt of disposal waste). When revenue is earned on services, such as management advisory fees and digester maintenance and repair services fees are recognized over the period the services are performed based on service milestones. The adoption of Topic 606 did not have a material impact on the timing or amounts of revenue and costs recognized in the Company’s consolidated financial statements and therefore did not have a material impact on our financial position, results of operations, equity or cash flows as of the adoption date or for the year ended December 31, 2018. The Company did not recognize any cumulative-effect adjustment to retained earnings upon adoption as the impact was immaterial. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. Lease Revenue Recognition — Rental, service and maintenance revenues relating to the Company’s rental agreements involve providing use of the Company’s digesters at customer locations, access to our software as a service and preventative maintenance over the term. The agreements generally provide for flat monthly payments that the Company believes are consistent with our costs and obligations underlying the agreements. The Company selected the practical expedient not to separate non-lease components from lease components. The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its digester units qualify as operating leases, for which the Company is the operating lessor. In order to determine lease classification as operating, the Company evaluates the terms of the rental agreement to determine if the lease includes any of the following provisions which would indicate sales type lease treatment: · The lease transfers ownership of the underlying asset to the lessee by the end of the lease term, · The lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise, · The Lease term is for the major part of the remaining economic life of the underlying asset. However, if the commencement date falls at or near the end of the economic life of the underlying asset, this criterion shall not be used for purposes of classifying the lease, · The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset or · The underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. Restricted Cash — Includes Restricted cash that is restricted as to its use, as it is held by a trustee in accordance with the West Virginia Economic Development Authority bond agreement. These amounts are held by the Company’s trustee in various bank accounts segregated for specific uses related to the construction and operation of the resource recovery facility. Amounts required to meet current operations of the Company have been classified as current in the accompanying consolidated balance sheets. Buildings, Equipment, Fixtures and Vehicles, Including Equipment Leased to Others — Buildings, equipment, fixtures and vehicles, including equipment leased to others, is stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the related assets, as follows: Years HEBioT facility 30 HEBiot equipment 15 Equipment leased to others 5 - 7 Computer software and hardware 3 - 5 Vehicles 5 Furniture and fixtures 7 - 15 The Company’s High Efficiency Biological Treatment (“HEBioT”) facility located in West Virginia was under construction through March 31, 2019. Included in the capitalized costs are construction, legal, leasehold improvements, and interest. MBT Facility Development Costs — The Company defers costs relating to on-going Mechanical Biological Treatment (“MBT”) facility development costs commencing upon the Company’s determination that the project will be completed. These site specific costs generally include external costs generally relating to legal, engineering and other costs relating to the acquisitions of land, permits and licenses. Upon commencement of construction, to the extent that costs relate to the facility, they are transferred to the construction in progress. Investments in Unconsolidated Entities —The Company has utilized the equity method of accounting for investments in companies if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of net income or loss is included in the Company’s consolidated operations as earning or loss from unconsolidated equity basis investments. In circumstances where the Company does not have the ability to exercise significant influence or control over the operating and financial policies of the investee, the investment is carried at cost, less impairment, adjusted for subsequent changes to estimated fair value up to the original cost. Long-Lived Assets — The Company assesses potential impairments to its long-lived assets if events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are reviewed annually for impairment, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. An impaired asset is written down to its estimated fair value based upon the most recent information available. Estimated fair market value is generally measured by discounting estimated future cash flows. Goodwill — The Company records as goodwill the excess of (i) the consideration transferred, the amount of any non-controlling interest in the acquiree, and the acquisition date fair value of any previous equity interest in the acquired entity over the (ii) fair value of the net identifiable assets acquired. The Company does not amortize goodwill; however, annually, or whenever there is an indication that goodwill may be impaired, qualitative factors are evaluated to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company’s test of goodwill impairment includes assessing qualitative factors and the use of judgment in evaluating economic conditions, industry and market conditions, cost factors, and entity specific events, as well as overall financial performance. Annual goodwill impairment analysis may include, but is not limited to the discounted cash flow method. Shipping Costs — Shipping and handling charges are recorded gross in both the revenue and in cost of revenue and amounted to $96,481 and $100,059 for the years ended December 31, 2019 and 2018, respectively. Advertising — The Company expenses advertising costs as incurred. Advertising expense amounted to $56,742 and $81,901 for the years ended December 31, 2019 and 2018, respectively. Research and Development — All research and development costs incurred by the Company are expensed as incurred. Deferred Financing Costs — Deferred financing costs relating to issued debt are included as a reduction to the applicable debt and amortized as interest expense over the term of the related debt instruments. Financial Instruments, Convertible Instruments, Warrants and Derivatives — The Company reviews its convertible instruments for the existence of embedded conversion features that may require bifurcation. If certain criteria are met, the bifurcated derivative financial instrument is required to be recorded at fair value. The Company also reviews and re-assesses, at each reporting date, any common stock purchase warrants and other freestanding derivative financial instruments and classifies them on the consolidated balance sheet as equity, assets or liabilities based upon the nature of the instruments. Comprehensive Income (Loss) — Comprehensive income (loss) for the Company consists of net earnings (loss) and foreign currency translation. Income Taxes — Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. Stock-Based Compensation — The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and is estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights. Costs equal to these fair values are recognized as expense ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of the grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in the accompanying consolidated statements of operations based upon the classification of the underlying employees or service providers with a corresponding increase to additional paid in capital. Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost. Loss per Share — The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” Dividends attributable to preferred stock, whether declared or accrued, and deemed dividends on down round feature are deducted from income attributable to common shareholders for purposes of earnings per share. The Company’s potential dilutive instruments include convertible preferred stock, options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Acquisition and Contribution Ag

Acquisition and Contribution Agreement	12 Months Ended
	Dec. 31, 2019
Acquisition and Contribution Agreement
Acquisition and Contribution Agreement	Note 3. Acquisition and Contribution Agreement On November 28, 2018, Company entered into a definitive agreement (the “MIPS”) with Entsorga USA, Inc. (“EUSA”) whereby EUSA agreed to sell, transfer and convey to BioHiTech 2,687 membership units of Entsorga West Virginia, LLC (“EWV”) (the “Membership units”) in consideration of 714,519 shares of BioHiTech’s newly created Series E convertible preferred stock (the “Sr. E CPS). At the time, EWV was a facility under construction that is intended to utilize HEBioT technology to divert municipal solid waste from landfills and to create an EPA recognized alternative commodity fuel, which has since commenced operations. On December 14, 2018, the EUSA transaction was consummated. The 714,519 shares of Sr. E CPS were valued at $1,886,630 based on the underlying common shares which the Sr. E CPS is convertible into. The total acquisition price of $2,863,583 is comprised of the aforementioned transaction, plus $976,953 of previously held equity in EWV. Upon consummation of the MIPS agreement BioHiTech owned a total of 4,410.4 membership units of EWV, comprised of the 2,687 units resulting from the MIPS agreement and 1,723.4 units previously acquired by BioHiTech during 2017. The 4,410.4 membership units represented 44.1% of the total membership units issued by EWV, which combined with BioHiTech’s control of EWV’s board, management and having the largest ownership block of EUSA, with the next largest block, which represents 34.1%, an entity over which BioHiTech has controlling financial interest, results in the investment being recognized in the Company’s financial statements on a consolidated basis. The estimated fair values of the assets acquired, and the liabilities assumed at the acquisition date are: December 14, 2018 Restricted cash $ 6,773,384 HEBioT facility under construction 32,784,920 MBT license 1,890,000 Total identified assets acquired 41,448,304 Account payable 65,943 Accrued liabilities 4,311,591 Long-term debt 31,085,902 Total liabilities assumed 35,463,436 Identifiable net assets acquired 5,984,868 Goodwill 58,000 Net assets acquired 6,042,868 Less non-controlling interest (3,179,285) Net identifiable assets acquired by Company $ 2,863,583 The following presents unaudited pro forma information as if the acquisition had occurred as of January 1, 2018. The pro forma results do not include any anticipated cost synergies or other effects of the integration of the acquired company. Pro forma amounts are not necessarily indicative of the results that actually would have occurred had the acquisition been completed on the dates indicated, nor is it indicative of future operating results of the combined company. (Unaudited) 2019 2018 Revenue $ 4,219,448 $ 3,359,324 Net loss attributable to Parent (7,622,948) (15,062,634) Proforma earnings per share – basic and diluted (0.56) (1.13) Following the consummation of the MIPS, on December 14, 2018, BioHiTech entered into a Contribution and Transaction Agreement (“CTA”) with Gold Medal Group, LLC (“GMG”) and a newly formed subsidiary Refuel America, LLC (“Refuel”) of the Company whereby GMG contributed $3,500,000 in cash and its 34.1% ownership interest in EVW (owned by GMG’s wholly owned subsidiary Apple Valley Waste Technologies, LLC) into Refuel and BioHiTech contributed it’s 44.1% interest in EWV, a technology license for a future HEBioT facility that BioHiTech carried at a value of $6,019,200 and $316,207 in capitalized costs relating to two separate HEBioT facility on-going projects. In exchange for the assets contributed, BioHiTech and GMG acquired 60% and 40%, respectively, of the membership units of Refuel, which approximate the carrying value of each of the BioHiTech and GMG assets contributed. As a result of there being a continuation in proportional ownership of the significant assets and the affiliate nature BioHiTech and GMG through a non-controlling interest of GMG being owned by BioHiTech and there being a management agreement between GMG’s largest subsidiary, Gold Medal Holdings, LLC (“GMH”) whereby BioHiTech provides executive management of GMH with control over the strategic and operational activities of GMH, the CTA transaction has been accounted for without separate acquisition accounting applied to the CTA elements.

Investments in Unconsolidated E

Investments in Unconsolidated Entities	12 Months Ended
	Dec. 31, 2019
Investments in Unconsolidated Entities
Investments in Unconsolidated Entities	Note 4. Investments in Unconsolidated Entities Entsorga West Virginia LLC - Effective March 21, 2017, the Company acquired a 17.2% interest in Entsorga West Virginia LLC EWV from the original investors at their original purchase price of $60,000 for each 1% of interest in EWV ($1,034,028). From March 21, 2017 through December 14, 2018 the Company recognized the investment utilizing the equity method of accounting due to its investment and its ability to influence operations and activities of EWV. On December 14, 2018, the Company consummated an additional acquisition of 2,687 membership units that resulted in the Company gaining control of EWV. As December 14, 2018, EWV is consolidated in the accompanying statement of operations and comprehensive loss. Through December 14, 2018, the Company had recognized losses through equity accounting of $193,102 for the year ended December 31, 2018, resulting in a carrying balance amounting to $823,161 as of December 14, 2018. As a result of the acquisition of additional membership units and change in control, this previously held equity investment was valued at fair value amounting to $976,953 with the corresponding gain of $153,792 reflected as in equity loss in affiliate in the accompanying consolidated statement of operations and comprehensive loss. Gold Medal Group, LLC – On January 25, 2018, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) to acquire 9.2% of the outstanding membership units (the “Units”) of Gold Medal Group, LLC (“GMG”), which is the owner of a traditional waste management entity. Pursuant to the Purchase Agreement, the Company acquired the Units from two unrelated parties in consideration $2,250,000 paid through the issuance of 500,000 shares of the Company’s common stock. During 2018, the Company’s investment in GMG was diluted from 9.2% to 2.9% due to additional GMG acquisitions and investments, including the CTA with the Company. As a result of the reduction in the ownership level and accordingly, a reduction in influence, effective December 14, 2018 the Company changed its prospective accounting for GMG from the equity method to the cost method. During the year ended December 31, 2018, the initial $2,250,000 investment in GMG was reduced by $562,617 in losses recognized prior to the change to cost basis accounting. As of December 31, 2019, the Company had no investments in unconsolidated investments as a result of its July 3, 3019 sale of its investment in Gold Medal Group, LLC (“GMG”), which was comprised of 2,250,000 GMG Investment Preferred Units and 2,250,000 Class A Common Units, to Gold Medal Equity, LLC (“GME”), the parent entity to GMG for total compensation of $2,250,000. As of July 3, 2019 these investments were carried by the Company with an adjusted cost of $1,687,383 resulting in a gain of $562,617 on July 3, 2019, which was recorded as gain on sale of affiliate investment in the accompanying consolidated statements of operations and comprehensive loss.

Accounts Receivable, net

Accounts Receivable, net	12 Months Ended
	Dec. 31, 2019
Accounts Receivable, net
Accounts Receivable, net	Note 5. Accounts Receivable, net Accounts receivable consists of the following as of December 31: 2019 2018 Accounts receivable $ 2,325,959 $ 513,336 Less: allowance for doubtful accounts receivable (170,038) (110,038) $ 2,155,921 $ 403,298 Allowance for doubtful accounts activities are as follows for the years ended December 31: 2019 2018 Balance at beginning of year $ (110,038) $ (134,288) Provision for doubtful accounts (103,499) (25,477) Amounts written off 43,499 49,727 Balance at end of year $ (170,038) $ (110,038)

Inventory

Inventory	12 Months Ended
	Dec. 31, 2019
Inventory
Inventory	Note 6. Inventory Inventory, comprised of finished goods and parts or assemblies, consist of the following as of December 31: 2019 2018 Equipment $ 119,996 $ 169,540 Parts and assemblies 347,788 330,308 $ 467,784 $ 499,848

Equipment on Operating Leases,

Equipment on Operating Leases, net	12 Months Ended
	Dec. 31, 2019
Equipment on Operating Leases, net
Equipment on Operating Leases, net	Note 7. Equipment on Operating Leases, net Equipment on operating leases consist of the following as of December 31: 2019 2018 Leased equipment $ 3,138,951 $ 3,054,097 Less: accumulated depreciation (1,413,953) (1,305,210) $ 1,724,998 $ 1,748,887 During the year ended December 31, 2019 and 2018, depreciation expense on equipment on operating lease, amounted to $431,833 and $353,189, respectively. The Company is a lessor of digester units under non-cancellable operating lease agreements expiring through June 2025. These leases generally have terms of three to five years and do not contain stated extension periods or options for the lessee to purchase the underlying assets. At the end of the leases, the lessee may enter into a new lease or return the asset, which would be available to the Company for releasing. During the year ended December 31, 2019 and 2018, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $1,483,852 and $1,174,772, respectively. The minimum future estimated contractual payments to be received under these leases as of December 31, 2019 is as follows: Year ending December 31, 2020 $ 1,357,645 2021 984,500 2022 684,095 2023 446,460 2024 and thereafter 127,209 $ 3,599,909

HEBioT Facility, Equipment, Fix

HEBioT Facility, Equipment, Fixtures and Vehicles, net	12 Months Ended
	Dec. 31, 2019
HEBioT Facility, Equipment, Fixtures and Vehicles, net
HEBioT Facility, Equipment, Fixtures and Vehicles, net	Note 8. HEBioT Facility, Equipment, Fixtures and Vehicles, net HEBioT facility, equipment, fixtures and vehicles consist of the following as of December 31: 2019 2018 HEBioT facility $ 31,142,974 $ — HEBioT equipment 7,388,896 — Computer software and hardware 112,629 112,500 Furniture and fixtures 48,196 48,196 Vehicles 50,319 50,319 38,743,014 211,015 Less: accumulated depreciation and amortization (1,321,681) (161,987) $ 37,421,333 $ 49,028 During the year ended December 31, 2019, depreciation expense relating to the HEBioT facility and equipment amounted to $1,139,269. During the years ended December 31, 2019 and 2018, depreciation expense relating to computers software and hardware, furniture and fixtures and vehicles amounted to $20,343 and $24,838, respectively. The Company’s HEBioT facility in Martinsburg, West Virginia accepted its first test loads of solid municipal waste on March 29, 2019 to commence commissioning and equipment calibration. The Company capitalizes all costs incurred to bring an asset to the condition and location necessary for its intended use. Included in the capitalized costs are construction, specialized equipment, legal, leasehold improvements, and interest. Capitalized interest relates to the State of West Virginia Revenue Bonds and amounted to $618,706 for the year ended December 31, 2019. The facility, while continuing commissioning, was placed in service on April 1, 2019.

MBT Facility Development and Li

MBT Facility Development and License Costs	12 Months Ended
	Dec. 31, 2019
MBT Facility Development and License Costs
MBT Facility Development and License Costs	Note 9. MBT Facility Development and License Costs MBT Facility Development and License Costs consist of the following as of December 31: 2019 2018 MBT Projects New Windsor, New York: Land acquisition $ — $ 66,000 Legal — 46,030 Survey and engineering — 300,624 — 412,654 Rensselaer, New York: Survey and engineering 235,229 153,554 Total MBT projects 235,229 566,208 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $94,500 of amortization as of December 31, 2019 1,795,500 1,890,000 Total Technology Licenses 7,814,700 7,909,200 Total MBT Facility Development and License Costs $ 8,049,929 $ 8,475,408 MBT Facility Development Costs New Windsor, New York As of December 31, 2018, the Company was pursuing local and state permits, and other approvals required to continue development of the project. On February 28, 2019, the Company elected to rescind an agreement for the purchase of real property with the Town of New Windsor in exchange for a return of the $66,000 paid by the Company under the rescinded contract and to relocate the project. While the Company is presently investigating several other sites for the project, as a result of abandoning the initial site, the Company has reflected an impairment expense of $346,654 relating to the site during 2019 in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations and comprehensive loss. Rensselaer, New York During 2018, the Company commenced initial development of a project in Rensselaer, NY. As of December 31, 2019, the Company has received local permits and has filed the required state permit applications, which are undergoing review by the New York State Department of Environmental Conservation. HEBioT Technology Licenses Technology License Agreement – Future Facility On November 1, 2017, the Company entered into a Technology License Agreement (the “License Agreement”) with Entsorgafin S.p.A. (“Entsorga”) whereby the Company acquired a license for the design, development construction, installation and operation of a High Efficiency Biological Treatment (“HEBioT”) renewable waste facility with a capacity of 165,000 tons per year. The patented HEBioT technology converts mixed municipal and organic waste to a US Environmental Protection Agency recognized alternative fuel source. The royalty payment for the license amounted to $6,019,200. This Technology License Agreement can be utilized at a future project and will be amortized once the facility is in operation. Technology License Agreement – Martinsburg, West Virginia In connection with the acquisition accounting applied to Entsorga West Virginia acquisition consummated on December 14, 2018, the facility License Agreement was valued at $1,890,000. During the year ended December 31, 2019 amortization expense amounted to $94,500, based on an estimated fifteen year life.

Intangibles Assets, net

Intangibles Assets, net	12 Months Ended
	Dec. 31, 2019
Intangibles Assets, net
Intangibles Assets, net	Note 10. Intangibles Assets, net Other assets, as of December 31, 2019 and 2018, include net digester distribution agreements amounting to $40,399 and $83,933, respectively. During the years ended December 31, 2019 and 2018, amortization expense, included in depreciation and amortization of operating expenses, amounted to $43,533 and $90,200, respectively. The agreements expire in 2021.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2019
Goodwill
Goodwill	Note 11. Goodwill As of December 31, 2019 and 2018, the Company has goodwill of $58,000 resulting from the Entsorga West Virginia, LLC acquisition on December 14, 2018.

Risk Concentrations

Risk Concentrations	12 Months Ended
	Dec. 31, 2019
Risk Concentrations
Risk Concentrations	Note 12. Risk Concentrations The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2019: Revenue, for the year ended December 31, 2019 $ 3,751,676 $ 467,772 $ 4,219,448 Non-current tangible assets, as of December 31, 2019 38,803,333 355,825 39,159,658 2018: Revenue, for the year ended December 31, 2018 $ 2,952,038 $ 407,286 $ 3,359,324 Non-current tangible assets, as of December 31, 2018 34,630,978 284,444 34,915,422 Credit risk — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) in the USA and the Financial Conduct Authority (“FCA”) in the UK insurance limits. Through December 31, 2019, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Major customers — During the year ended December 31, 2019, one customer represented at least 10% of revenues, accounting for 48.2% (Gold Medal Group, LLC, an affiliated entity, “GMG”) of revenues. During the year ended December 31, 2018, one customer represented at least 10% of revenues, accounting for 30.7% (GMG) of revenues. As of December 31, 2019 one customer represented at least 10% of accounts receivable, accounting for 58.9% (GMG) of accounts receivable. As of December 31, 2018, one customer represented at least 10% of accounts receivable , accounting for 32.8% (GMG) of accounts receivable. Vendor concentration — During the year ended December 31, 2019, one vendor represented at least 10% of costs of revenue, accounting for 23.1% (GMG) of costs of revenue. During the year ended December 31, 2018, two vendors represented at least 10% of costs of revenue, accounting for 25.1% (a 1.4% shareholder) and 11.0% costs of revenue. As of December 31, 2019, one vendor represented at least 10% of accounts payable accounting for 54.4% (GMG) of accounts payable. As of December 31, 2018, one vendor represented at least 10% of accounts payable, accounting for 12.0% (a 1.4% shareholder) of accounts payable. Affiliate relationship — GMG owns a 40% interest in Refuel America, LLC, a consolidated subsidiary of the Company. GMG’s subsidiaries, which are not consolidated in the Company’s financial statements have several business relationships with the Company and its subsidiaries that result in revenues and expenses noted above. See Note 20. Related Party Transactions.

Line of Credit, Notes Payable,

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt	12 Months Ended
	Dec. 31, 2019
Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt
Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt	Note 13. Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt Notes, lines, advances and long-term debts are comprised of the following as of December 31: 2019 2018 Related Related Total Party Total Party Line of credit $ 1,479,848 $ — $ 1,469,330 $ — Senior secured promissory note 4,160,490 — 3,851,305 — Junior promissory note 949,434 949,434 926,211 926,211 Note payable 100,000 — 100,000 — Advance from related party 210,000 210,000 — — Long term debt - current and long-term portion 12,806 — 21,971 — Line of Credit —On February 2, 2018, the Company’s subsidiary, BHT Financial, LLC (“BHTF”) entered into a new Credit Agreement (the “Credit Agreement”) and a Master Revolving Note (the “Note”) with Comerica that provides for a facility of up to $1,000,000, secured by the assets of BHTF. The Credit Agreement and Note were amended on November 9, 2018 to increase the facility to $1,500,000. The Note does not have any financial covenants, carries interest at the rate of 3%, plus either the Comerica prime rate or a LIBOR-based rate, (5.71% and 6.52% as of December 31, 2019 and December 31, 2018, respectively) and matured on January 1, 2020, which was subsequently extended to March 31, 2020 and remains outstanding as of the date of this filing. The Company expects to obtain an amended agreement through the remainder of 2020. The line of credit is secured by the assets of BHTF and is personally guaranteed by the Company’s Chief Executive Officer, Frank E. Celli and James C. Chambers, a director. As of December 31, 2019, the $1,500,000 balance outstanding is presented net of $34,948 in issuance costs associated with the financing, net of $14,796 in amortization. As December 31, 2018, the $1,500,000 balance outstanding is presented net of $34,948 in issuance costs associated with the financing, net of $4,278 in amortization. Amortization is calculated on the effective interest method, which is included in interest expense in the accompanying consolidated statements of operations and comprehensive loss. Michaelson Senior Secured Term Promissory Financing – On February 2, 2018, the Company and several of the Company’s wholly-owned subsidiaries entered into and consummated a Note Purchase and Security Agreement (the “Purchase Agreement”) with Michaelson Capital Special Finance Fund II, L.P. (“ MCSFF ”) to issue a senior secured term promissory note in the principal amount of $5,000,000 (the “Note”). The Note is not convertible and accrues interest at the rate of 10.25% per annum. The Note provides for certain financial covenants that were not met as of December 31, 2019 and December 31, 2018 and a waiver of such was granted by MCSFF. The Note is to be repaid in eight, equal, quarterly installments of $625,000 commencing on May 15, 2021 and ending February 2, 2023 (the “Maturity Date”). Additionally, the Note is secured by a general security interest in all of the Company’s assets as well all of the assets of the Company’s subsidiaries, excluding those of Entsorga West Virginia LLC which is subject to superior security interests relating to the Entsorga West Virginia LLC WVEDA bonds. Further, the Company’s Chief Executive Officer, guaranteed a portion of the Registrant’s obligations to MCSFF. In connection with the issuance of the Note, the Company issued MCSFF 320,000 shares of the Registrant’s common stock, par value $0.0001 per share. As of December 31, 2019 and 2018, the carrying balance of the Note is comprised of $5,000,000 face value, less $1,212,121 allocated to the common stock issued based upon the market value on the date issued, less associated amortization of $485,878 and $223,443, respectively, on the stock discount, less deferred financing costs of $211,187, less $97,920 and $51,170, respectively, of associated deferred financing cost amortization. All amortization is computed on the effective interest method and included in interest expense in the accompanying consolidated statements of operations and comprehensive loss. Junior Promissory Note – On February 2, 2018, the Company entered into a Securities Exchange and Note Purchase Agreement (the “Exchange Agreement”) with Frank E. Celli, the Company’s Chief Executive Officer, whereby Celli exchanged $4,500,000 in a note receivable from the Company and $544,777 in advances made to the Company for $4,000,000 of the Registrant’s Series C Convertible Preferred Stock, par value $0.0001 (the “Series C Preferred Stock”) and a junior promissory note (the “Junior Note”) amounting to $1,044,477, which is carried net of discounts amounting to $135,823, less associated amortization of $40,780 and $17,557 as of December 31, 2019 and 2018, respectively. The Junior Note, which is subordinated to the senior secured note, is not convertible, accrues interest at the rate of 10.25% per annum and matures on February 2, 2024. Note Payable — As of December 31, 2019 and 2018, the note, with interest at 10%, had a remaining balance outstanding of $100,000 and matured on January 1, 2020 and remains outstanding as of the date of this filing. The Company expects to amend the agreement to extend the maturity date through the remainder of 2020. Long Term Debt — Represents two loans collateralized by vehicles with interest ranging from 1.9% to 4.99%, each with amortizing principal payment requirements through 2020 and 2022, respectively. Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — as of December 31, 2019, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Year Ending December 31, Amortizing Non-Amortizing Total 2020 $ 4,605 $ 100,000 $ 104,605 2021 4,380 1,875,000 1,879,380 2022 3,821 2,500,000 2,503,821 2023 — 625,000 625,000 2024 and thereafter — 1,044,477 1,044,477 Total $ 12,806 $ 6,144,477 $ 6,157,283

Entsorga West Virginia, LLC WVE

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	12 Months Ended
	Dec. 31, 2019
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	Note 14. Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds During 2016, Entsorga West Virginia LLC (the “Borrower”) was issued $25,000,000 in Solid Waste Revenue Bonds from the West Virginia Economic Development Authority (the “WVEDA Bonds”). The WVEDA Bonds were issued in two series with one for $7,535,000 bearing interest at 6.75% per annum with a maturity date of February 1, 2026 and the second for $17,465,000 bearing interest at 7.25% per annum with a maturity of February 1, 2036. Both series were issued at par. The 2026 series was payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. The 2036 series is payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. Repayment of principal is by way of sinking fund. During 2018, the 2016 Indenture Trust and Loan Agreement were amended and restated effective November 1, 2018. These amendments provided for a third series of bonds amounting to $8,000,000 bearing interest at 8.75% per annum with a maturity date of February 1, 2036, with special event triggered pre-payment requirements. This series was issued at par. The 2036 series is payable with interest-only payments through February 1, 2020 then annual payments of principal and semi-annual payments of interest through maturity. Repayment is by way of sinking fund. The outstanding balance of the WVEDA Bonds as of December 31, 2019 and 2018 is $33,000,000, which is presented net of unamortized debt issuance costs amounting to $2,207,759 and $2,145,608, less associated amortization of $415,185 and $231,510, respectively, which includes amortization prior to the Company’s control acquisition in 2018. Amortization is calculated on the effective interest method, which is included in interest expense in the accompanying consolidated statements of operations and comprehensive loss. The loan agreement and indenture of trust place restrictions on the Borrower and its members regarding additional encumbrances on the property, disposition of the property, and limitations on equity distributions. The loan agreement also provides for financial covenants, which became effective on September 30, 2019. As of December 31, 2019 the Company was not in compliance with all of the financial covenants and subsequently was in default on a principal repayment due in February 2020 and has entered into a forbearance agreement with the bond trustee that provides they will not accelerate the repayment of the bonds due to the defaults through April 2, 2021. The future sinking fund payments by the Borrower as of December 31, 2019 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2020 $ 1,160,000 $ — $ 230,000 $ 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 965,000 — 300,000 1,265,000 2024 and thereafter 3,295,000 17,465,000 6,940,000 27,700,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000 In connection with the November 1, 2018 amendment and restatement of the WVEDA Bonds, Comerica Bank issued a standby letter of credit in the amount of $1,250,000 (the “SbyLoC”) for the benefit of the WVEDA Bond trustee that is collateralized by the Company’s cash.

Equity and Equity Transactions

Equity and Equity Transactions	12 Months Ended
	Dec. 31, 2019
Equity and Equity Transactions
Equity and Equity Transactions	Note 15. Equity and Equity Transactions The Company has 50,000,000 shares of its $0.0001 par common stock and 10,000,000 shares of blank check preferred stock authorized by its shareholders. As of December 31, 2019 and December 31, 2018, 17,300,899 and 14,802,956 shares of common stock have been issued; and 3,179,120 and 3,159,120 shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,042,287 in accumulated, but undeclared preferential dividends as of December 31, 2019, as follows: Shares Outstanding Designation Designated Shares Par Value Stated Value December 31, 2019 December 31, 2018 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 145,312 163,312 Series B Convertible Preferred Stock 1,111,200 0.0001 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 100.00 18,850 — Series E Convertible Preferred Stock 714,519 0.0001 2.64 264,519 564,519 Under the terms of the Company’s senior lender agreements, the Company is restricted from paying dividends in cash, but is allowed to pay dividends in common stock. The Company, since its merger in 2015, has not paid any cash or stock dividends on common stock. The consolidated financial statements include less than 100% owned and controlled subsidiaries and include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries. Entsorga West Virginia LLC through its limited liability agreement and the agreements related to its WVEDA Bonds have restrictions on distributions to and loans to owners while the WVEDA Bonds are outstanding. On September 9, 2019 the Company issued 1,877,666 registered shares of its $0.0001 par common stock through its Registration Statement on Form S-3 declared effective on July 11, 2018, by the Securities and Exchange Commission. The shares were offered through a confidentially marketed public offering and were sold at a per share price of $1.80 per share. The gross proceeds of the offering amounted to $3,379,799, which net of placement fees of $195,461, legal fees of $135,359, regulatory filing fees of $8,000 and $5,422 of other costs resulted in net proceeds to the Company of $3,035,557. In connection with the placement agent fees, the Company issued warrants for 56,330 shares, exercisable between March 11, 2020 and September 10, 2019 at an exercise price of $2.25 per warrant share. Series A Redeemable Convertible Preferred Stock — Due to the existence of redemption features, the stock is accounted for as temporary equity (similar accounting treatment to debt). Amortization of discounts and deferred issuance costs are reflected as interest expense in the accompanying consolidated statements of operations and comprehensive loss. On March 30, 2018, the Company and holders of the Series A Convertible Preferred Stock (“Series A Preferred”) amended and restated to provide the holders with the option to redeem their shares anytime following the first anniversary if the Company consummates an equity financing in an amount equal to the stated value of the Series A Preferred, plus any and all accrued dividends. In addition, the dividend on the Series A Preferred was amended to nine percent (9%), the first dividend payment date was amended to June 30, 2018 and the conversion price, by the terms of the Certificate of Designation, was set at $4.50 per share of the Company’s common stock. In addition, the Company agreed to issue the holders, within 5 business days after the first day of trading of the Company’s common stock on an Eligible Market, warrants to purchase up to 180,000 shares of Common Stock at an exercise price of $5.00 per share and expiring in four (4) years on a pro-rata basis to the holders of record of the Series A Preferred Shares at the time of such issuance. The warrants for 180,000 shares of common stock were valued utilizing the Black-Scholes modelling technique utilizing stock prices of $4.05, an exercise price of $5.00, a standard deviation (volatility) of 41.8%, a risk-free interest rate of 2.9% with a term of 4 years. The resulting $246,319 value has been recognized as other interest expense and additional paid in capital. In connection with the amendment, the Company redeemed $317,000 in stated value shares at stated value, which resulted in the Company reflecting an additional interest expense of $157,455 to write off unamortized discounts and costs relating to the shares redeemed. During June of 2018, the holder converted 40,000 shares with an aggregate stated value of $200,000 of stated value for 44,444 shares of common stock. In connection with the conversion the Company reflecting an additional interest expense of $73,461 to adjust unamortized discounts and costs relating to the shares converted. During August of 2018, the holder converted 46,689 shares with an aggregate stated value of $233,445 of stated value for 51,876 shares of common stock. In connection with the conversion the Company reflecting an additional interest expense of $47,767 to adjust unamortized discounts and costs relating to the shares converted. During October of 2018, the holder converted 20,000 shares with an aggregate stated value of $100,000 of stated value for 22,222 shares of common stock. As of December 31, 2018, the net Series A Preferred Stock balance of $816,553 is comprised of 163,312 shares at stated value. The original issue discount of $166,699, bifurcated warrants of $403,630, bifurcated beneficial conversion feature of $535,630 and deferred issuance costs of $30,000 have been fully amortized through December 31, 2018. Interest expense resulting from the amortization amounted to $1,043,715 during the year ended December 31, 2018 and is reflected in the accompanying consolidated statements of operations and comprehensive loss as interest expense. On September 9, 2019 the holder of Series A Preferred Stock converted 18,000 shares of Series A preferred stock for 50,000 shares of the Company’s $0.0001 par common stock. On September 26, 2019, November 4, 2019, November 14, 2019, December 2, 2019 and December 16, 2019 the Company paid $50,000, $50,000, $50,000, $35,000 and $15,000 of Series A preferred stock accrued dividend through the issuance of 27,778, 27,778, 27,778, 19,444 and 8,333 shares of the Company’s $0.0001 par common stock, respectively. As of December 31, 2019 the outstanding shares of Series A Preferred Stock amounted to 145,312 with a stated value of $726,553 and the accrued dividends amounted to $56,886. Series C Convertible Preferred Stock — The Series C Preferred Stock has a stated value of $10.00 per share and is convertible, at the holder’s option, into the Registrant’s common stock, par $0.0001, at an initial conversion price of $4.75 per share. The Series C Preferred Stock is non-redeemable, has voting rights together with the common stock, par $0.0001, at the rate of 4 votes to 1 and accrues dividends at 10.25% of the stated value outstanding. As of December 31, 2019 and 2018, the Series C Preferred Stock is comprised of $4,275,000 face value, less $556,283 warrant valuation and beneficial conversion features of $668,575 reflected in additional paid in capital. On February 2, 2018, in connection with and as a condition precedent to the closing of the MCSFF Note, the Company entered into a Securities Exchange and Note Purchase Agreement (the “Exchange Agreement”) with Frank E. Celli, the Company’s Chief Executive Officer, whereby Celli exchanged $4,500,000 in a note receivable and $544,777 in advances made to the Company for $4,000,000 of the Company’s Series C Preferred Stock and a junior promissory note (the “Junior Note”). The Junior Note, which is subordinated to the MCSFF Note, is not convertible, accrues interest at the rate of 10.25% per annum and matures on February 2, 2024. In connection with this transaction, the Registrant also issued Celli warrants to purchase 421,053 shares of Common Stock, initially exercisable at $5.50 per share which expire in five (5) years. The warrants for 421,053 shares of common stock were valued utilizing the Black Scholes modelling technique utilizing stock price of $4.95, an exercise price of $5.50, a standard deviation (volatility) of 40.48%, a risk-free interest rate of 2.95% based on the date of issue, with a term of 5 years. On March 23, 2018, the Company entered into a Securities Exchange Agreement (the “Exchange Agreement”) with Frank J. Celli, the father of the Company’s Chief Executive Officer, whereby Frank J. Celli exchanged $275,000 in a note receivable from the Company for $275,000 of the Company’s Series C Preferred Stock. In connection with this transaction, the Registrant also issued Frank J. Celli warrants to purchase 28,948 shares of Common Stock, initially exercisable at $5.50 per share which expire in five (5) years. The warrants for 28,948 shares of common stock were valued utilizing the Black Scholes modelling technique utilizing stock price of $4.05, an exercise price of $5.50, a standard deviation (volatility) of 41.77%, a risk-free interest rate of 2.91% based on the date of issue, with a term of 5 years. Series D Convertible Preferred Stock — On February 11, 2019 the Company filed a Certificate of Designation for 20,000 shares of Series D Convertible Preferred Stock that was amended on May 1, 2019 (“Sr. D CPS”). The Sr. D CPS is initially convertible into shares of the Company’s common stock at the price of $3.50 per share based on the Sr. D CPS’s stated value being converted. Each share of the Sr. D CPS has a stated value of $100 and has dividends at the rate of 9% payable annually in arrears in cash or at the Company’s option, in common stock based upon the then in effect conversion price. The Sr. D CPS also has an alternative dividend provision based upon the cash flow distributed to the parent from the Company’s next HEBioT facility, excluding the plant in Martinsburg, West Virginia, (the “Next Facility”) based upon the Sr. D CPS proportional investment in the facility. The Sr. D CPS also has an alternative conversion based upon a multiple the annualized EBITDA of the Next Facility converted at the higher of the conversion rate in effect or the market price of the Company’s common stock if higher. During 2019, the Company received subscriptions and investments totaling $1,885,000, which were issued 18,850 shares of Sr D CPS. In addition to the Sr. D CPS, each holder received warrants to acquire 50% of the shares that the Sr. D CPS is convertible into with an initial exercise price of $3.50 per share and an expiration on the fifth year anniversary. A total of 269,296 five-year warrants with an exercise price of $3.50 were issued to the Sr. D CPS holders that were valued utilizing the Black-Scholes modelling technique utilizing stock prices ranging from $1.88 to $2.70, a standard deviation (volatility) ranging from 44.55% to 46.38% and a risk-free rate interest rate ranging from 1.74% to 2.56% based on the date of the investment. The model includes subjective input assumptions that can materially affect the fair value estimates. The allocated fair value of the warrants amounting to $190,299 has been reflected in additional paid in capital. In connection with the offering and issuance of the Sr D CPS, the holder of the Series A convertible preferred stock was issued 116,651 warrants in the form issued to the Sr D CPS holders. These warrants, which were reflected as a cost of issuing the Sr D CPS, were valued utilizing the Black-Scholes modelling technique utilizing a stock price of $2.25, a standard deviation (volatility) of 46.23% and a risk-free interest rate of 1.89% on the date of issuance. Series E Convertible Preferred Stock — On December 14, 2018, the Company consummated a transaction with Entsorga USA, Inc. whereby EUSA agreed to sell, transfer and convey to the Registrant Two Thousand Six Hundred Seventy-Six and 60/100 (2,676.60) common membership units of EWV in consideration for 714,519 newly issued shares of stock of the Company’s newly created Series E Preferred Stock, par value $0.0001, (the “Series E Shares”) convertible into 714,539 shares (the “Conversion Shares”) of the Registrant’s common stock, par value $0.0001 per share (the “Common Stock”). The Series E Shares with a stated value of $2.64 per share is convertible into shares of the Registrant’s common stock, par value $0.0001 per share and does not earn any dividends and has no special voting rights. The Series E Shares are convertible at the rate of one share of common stock for each Series E Share converted, subject to adjustment for stock splits and reclassifications. Immediately following the issuance of the Series E Shares, 150,000 Series E Shares were converted into 150,000 shares of common stock. During the year ended December 31, 2019, an additional 300,000 Series E Shares were converted into 300,000 common shares resulting in 264,419 Series E Shares outstanding as of December 31, 2019. Warrants — In connection with the issuance of convertible debt, preferred and common stock and in connection with services provided, the Company has the 4,674,261 warrants to acquire the Company’s common stock outstanding as of December 31, 2019, as follows: Weighted Average Exercises Expiring During the Year Warrant Exercise Price Price Ending December 31, Shares per Share per Share 2020 $ 3.50 $ 3.50 2021 $ 1.80 to $3.30 $ 3.25 2022 $ 1.80 to $5.00 $ 2.60 2023 740,749 $ 1.80 $ 1.80 2024 385,945 $ 1.80 $ 1.80 2025 56,330 $ 2.25 $ 2.25 The following table summarizes the outstanding warrant activity for the year ended December 31, 2019: Outstanding, January 1, 2019 Issued Issued as a result of common stock offering at $1.80 per share Exercised — Expired — Outstanding, December 31, 2019 In connection with the confidentially marketed public offering that closed on September 9, 2019 at a price per common share of $1.80, 70 warrants representing the right to acquire 1,992,325 shares with down-deal exercise price features were re-priced to an exercise price of $1.80. In connection with the modification the value of the warrants was recalculated based upon the value immediately prior to the modification and immediately after the modification. In connection therewith the Company utilized Black Scholes valuation models utilizing volatility of 50.56% and a risk free rate of 1.51% together with the contractual remaining terms of each warrant. This revaluation increased the value of the warrants by $405,324, which has been reflected as an increase in accumulated deficit and additional paid in capital. In accordance with Accounting Standards Update No. 2017-11, this increased valuation is not charged to the consolidated statement of operations and comprehensive loss however, it is included as an adjustment to net loss attributable to parent in arriving at net loss per common share – basic and diluted. Also in connection with the confidentially marketed public offering that closed on September 9, 2019, the holder of the Series A preferred stock had the option to require that the Company redeem shares of Series A preferred stock up to an amount representing 50% of the offering. In connection therewith, the holder agreed to not require the redemption in exchange for an extension of one year to the warrants originally issued in connection with the Series A preferred stock; all other contractual terms of the Series A preferred stock remained unchanged. Utilizing the same Black Scholes valuation model variables as utilized in connection with the down deal, above, the change in valuation amounted to $49,160. As the redemption features remained unchanged, the Series A preferred stock continues to be accounted for as temporary equity, which require that the modification be charged to the consolidated statement of operations and comprehensive loss.

Equity Incentive Plans

Equity Incentive Plans	12 Months Ended
	Dec. 31, 2019
Equity Incentive Plans
Equity Incentive Plans	Note 16. Equity Incentive Plans The Company has two equity incentive plans: 2015 Equity Incentive Plan — During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. 2017 Executive Incentive Plan — During 2017, the shareholders approved the 2017 Executive Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 1,000,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. The shares underlying the plans, which total 1,750,000, have been registered by the Company under a Form S‑8 Registration Statement declared effective July 7, 2018 by the Securities and Exchange Commission. Compensation expense related to stock options and restricted stock for the years ended December 31, was: 2019 2018 Stock options $ 138,673 $ 164,906 Restricted stock units 960,894 671,466 $ 1,099,567 $ 836,372 The following summarizes the Company’s stock option activity for the year ended December 31, 2019: Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding – January 1, 2019 482,082 3.71 7.80 — Granted — — — — Exercised — — — — Forfeited, Canceled or Expired (118,256) 3.71 — — Outstanding – December 31, 2019 363,826 3.71 7.34 — Exercisable – December 31, 2019 233,475 3.73 6.73 — Total unrecognized compensation expense related to the unvested options at December 31, 2019 and 2018 amounts to $159,657 and $462,297, which the weighted average period that the expense is expected to be recognized is 1.77 and 2.44 years, respectively. On June 7, 2018 the Company granted 297,790 non-qualified stock options with an exercise price of $3.68 per share with a total value of $595,563 based upon using the Black-Scholes option pricing model with the following assumptions: Risk-free interest rate % Expected dividend yield % Expected volatility % Expected term in years 6.36 There were no grants of non-qualified stock options during 2019. Restricted Stock Units – There were no grants of restricted stock units (“RSU”) during 2019. During 2018, the Company granted or modified 768,572 RSUs to certain employees generally vesting over a three-year period, subject to continued service on each applicable vesting date. The RSUs have no voting or dividend rights. The unamortized cost of the modified RSUs at the time of modification is being amortized over the modified vesting periods. The fair value of the common stock on the date of the grant ranged from $3.50 to $4.05 per share based upon the quoted closing price of the Company’s common stock on the grant date. The aggregate grant date fair value of the award amounted to $2,472,246 which will be recognized as compensation expense over the vesting period. As of December 31, 2019 and 2018, the aggregate intrinsic value of the unvested RSUs, determined by multiplying the anticipated number of RSUs that will vest by the closing market price of the underlying common stock, was $495,941 and $1,203,240, respectively. Total unrecognized compensation expense related to the unvested RSUs at December 31, 2019 and 2018 amounts to $766,555 and $1,884,479, respectively, and is expected to be recognized over a weighted average period of 1.43 and 2.34 years, respectively. The following summarizes the Company’s RSU activity for the years ended December 31, 2019 and 2018: Number of Shares Unvested balance at January 1, 2018 171,112 Granted 768,572 Vested (114,997) Forfeited or Canceled (81,946) Unvested balance at December 31, 2018 742,741 Granted or modified — Vested (410,891) Forfeited or Canceled (40,120) Unvested balance at December 31, 2019 291,730

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Taxes
Income Taxes	Note 17. The components of income tax expense (benefit) from operations for the year ended December 31, was: 2019 2018 US Federal: Deferred $ 1,664,794 $ 1,992,255 State and local: Deferred 256,238 (618,573) Non-US: Deferred 7,693 58,880 Change in valuation allowance (1,928,725) (1,432,562) Income tax provision $ — $ — The reconciliation of differences between the Federal statutory tax rate and the Company’s effective income tax rate for the year ended December 31, was: 2019 2018 U. S. Federal Statutory rate (21.0) % (21.0) % Non-U.S. losses — 0.1 Impact of US statutory tax rate change — — Impact of US statutory tax rate change on valuation allowance — — Local taxes, net of benefit (2.5) 4.2 Nondeductible expenses 5.9 9.6 Other (1.2) (2.6) (18.8) (9.7) Change in valuation allowance 18.8 9.7 Effective income tax rate — % — % The Company’s net deferred tax assets and valuation allowance as of December 31, was: 2019 2018 Deferred tax assets: Net operating losses - Federal $ 6,000,170 $ 3,984,049 Net operating losses - State 1,055,936 802,934 Net operating losses - Non-US 185,556 177,864 Stock-based compensation 649,907 434,487 Accrued expenses 536,348 441,756 Interest — 524,677 Lease liability 212,177 — Other, net 242,793 88,157 8,882,887 6,453,924 Deferred tax liabilities: Property and equipment - Federal (366,413) (86,344) Right of use asset (220,169) — (586,582) (86,344) Net deferred tax assets 8,296,305 6,367,580 Valuation allowance (8,296,305) (6,367,580) Net deferred tax assets $ — $ — For the years ended December 31, 2019 and 2018 there was no net provision for income tax due to the losses incurred and management’s evaluation of the recovery of the tax asset resulting in net operating loss carryforward. As of December 31, 2019, the Company had net operating loss carryforwards of approximately $28,572,000 and $14,325,000 for federal and state income tax purposes, respectively. For purposes of Internal Revenue Code Section 382, the annual utilization of net operating loss carryovers are subject to limitation resulting from a more than 50% ownership change as determined under the regulations, which occurred during the year ended December 31, 2019. The federal net operating losses of approximately $14,200,000, generated in tax years beginning before January 1, 2018, will begin to expire in 2036 if not utilized. The balance of the net operating losses, approximately $14,372,000 do not expire.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies
Commitments and Contingencies	Note 18. Commitments and Contingencies During the year ended December 31, 2019 the Company was involved in the following legal matters. The Company had accrued their contractual obligations but disputed payment for a consulting services agreement with Tusk Ventures LLC (“Tusk”), in which Tusk claim that it is owed $250,000 pursuant to an agreement. This matter was filed in the Supreme Court of the State of New York, New York County in April 2017. This matter was settled on April 23, 2019. In connection with the settlement, the Company issued to the plaintiff 75,000 shares of its common stock. On February 7, 2018, Lemartec Corporation (“Lemartec”) filed a complaint against the Company in the United States District Court for the Northern District of West Virginia arising out of the construction of the Company’s resource recovery facility in Martinsburg, West Virginia alleging breach of contract and unjust enrichment. The Company has filed its answer and counterclaims for damages against Lemartec and cross claims against Lemartec’s performance bond surety, Philadelphia Indemnity Insurance Company. The trial was scheduled to begin in August 2020. Subsequent to year end and prior to the start of the trial, on March 12, 2020 the Company entered into a settlement agreement that detailed the full and final mutual release. The settlement agreement provides that the Company pay Lemartec $775,000 in installments of $475,000 within 60 days of the execution of the settlement agreement and $25,000 each month thereafter for 12 months. The Company’s consolidated financial statements as of December 31, 2019 reflects this liability given the nature of the subsequent event. It is management’s opinion that the resolution of these known claims will not materially effect the Company’s future financial position, results of operations, or cash flows. From time to time, the Company may be involved in other legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations

Leases

Leases	12 Months Ended
	Dec. 31, 2019
Leases
Leases	Note 19. Leases Effective January 1, 2019, the Company implemented Accounting Standards Codification 842, Leases. The guidance requires lessees to recognize most leases on the balance sheet but does not change the presentation of expenses on the income statement. The two permitted transition methods under the guidance are the modified retrospective transition approach, which requires application of the guidance for all comparative periods presented, and the cumulative effect adjustment approach, which requires prospective application at the adoption date. The Company utilized the optional transition method to assess the impact of this guidance on the Company’s financial statements and related disclosures, including the increase in the assets and liabilities on our balance sheet from lessee perspective. The Company completed a comprehensive review of its leases that were impacted by the new guidance. As part of the adoption, the Company elected the ‘package of practical expedients,’ which permits the Company not to reassess under the new standard the Company’s prior conclusions about lease identification, lease classification and initial direct costs, therefore the Company did not restate prior comparative periods. The Company rents its headquarters and attached warehousing space from a related party (see Note 16) and has a land lease relating to the Martinsburg, WV HEBioT facility under operating leases. The HEBioT facility land lease has an initial term of 30 years, plus four 5-year extensions. For purposes of our determination of lease liabilities, extensions were not included. As the leases do not provide an implicit rate, the Company used incremental borrowing rates in determining the present value of lease payments. For the HEBioT facility land lease a rate of 11% was utilized and a rate of 10.25% was used on the other leases. The current portion of the lease liabilities of $146,926 is included in accrued expenses and liabilities. Total lease costs under operating leases amounted to $221,423 and $155,060 for the years ended December 31, 2019 and 2018. Maturities of lease liabilities under these leases, which have a weighted average remaining term of 25.3 years, as of December 30, 2019 is: Year Ending December 31, 2020 $ 146,926 2021 109,000 2022 113,000 2023 113,000 2024 and thereafter 2,980,750 Total lease payments 3,462,676 Less imputed interest (2,401,682) Present value of lease liabilities $ 1,060,994 During the year ended December 31, 2019, the Company recognized operating lease right of use assets in exchange for lease liabilities amounting to $1,045,755 and had operating cash flows for operating leases amounting to $195,003 for the year then ended.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Related Party Transactions
Related Party Transactions	Note 20. Related Party Transactions Related parties include Directors, Senior Management Officers, and shareholders, plus their immediate family, who own a 5% or greater ownership interest at the time of a transaction. Related parties also include GMG and its subsidiaries. As of December 31, 2019, GMG is controlled by several private equity funds managed by Kinderhook Industries. The Company initially invested in GMG on January 25, 2018. On July 3, 2019 the Company sold its ownership interests in GMG to an entity controlled by Kinderhook Industries. As discussed in Note 3, on December 14, 2018 the Company formed a new consolidated subsidiary, Refuel America, LLC (“Refuel”) into which the Company contributed specified assets, including its ownership interest in Entsorga West Virginia, LLC (“EWV”) and other HEBioT development assets. In exchange for a 40%, but non-controlling interest in Refuel, GMG contributed its ownership interests in EWV and $3,500,000 in cash. During the year ended December 31, 2019, GMG made an additional capital contribution into Refuel. In connection with GMG’s additional investment, the Company made an additional $2,100,000 investment in Refuel. During 2018 GMG acquired as regional waste management entity, Apple Valley Waste (“AVW”), with operations located in West Virginia, Maryland and Pennsylvania. As part of this acquisition, GMG also acquired its interests in EWV that were contributed to Refuel. Prior to GMG’s acquisition of AVW and the Company’s investments and control acquisition of EWV, in order for EWV to receive the proceeds from the Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Note 14), EWV and AWV had entered into several agreements. Business Services Agreement – On February 2, 2016, EWV and AVW entered into an agreement that whereby AVW provides solicitation, logistics management, human resources, accounting and financial management, and other general administrative and support services. This agreement has a ten-year term with automatic renewals for five-year periods, subject to prior notice of non-renewal. The agreement provides for a fee of $72,000 annually during construction and $367,600 annually upon commencement of operations. External costs incurred on behalf of EWV that are paid by AVW are rebilled at cost to EWV. Solid Waste Delivery / Disposal Agreements – On November 30, 2015 EWV and several AVW subsidiaries (the “Subsidiaries”) entered into agreements that provide that the Subsidiaries will deliver a minimum tonnage of municipal solid waste (52,000 tons) and that EWV will accept up to 66,250 tons of municipal solid waste. The contracts with minimum delivery tonnage have disposal fees (tipping fees) with a weighted average price of $56.37 per ton, subject to change annually. The contracts also provide that if the Subsidiaries fail to deliver the minimum tonnage, they will pay a fee of $20 for each shortfall ton. The contracts also provide that if EWV refuses to accept tonnage presented for disposal within the minimum tonnage that EWV will pay the Subsidiaries a fee of $20 per each refused ton. Each of the agreements has a ten-year term with automatic renewals for five-year periods, subject to prior notice of non-renewal. The face amount of direct related party assets and liabilities and other transactions or conditions as of or for the year ended December 31, was: 2019 2018 Assets: Accounts receivable (a) (b) (c) $ 1,370,867 $ 168,588 Intangible assets, net, included in other assets (d) 40,399 83,933 Liabilities: Accounts payable (d) (e) (f) (g) 2,531,034 160,761 Accrued interest payable 46,796 46,796 Long term accrued interest (h) 1,510,193 1,305,251 Advance from related party (i) 210,000 — Junior promissory note (h) 949,434 926,211 Other: Line of credit guarantee (j) 1,479,848 1,469,330 The table below presents direct related party expenses or transactions for the year ended December 31, 2019. Compensation and related costs for employees of the Company are excluded from the table below. 2019 2018 Management advisory and other fees (a) (b) $ 975,000 $ 1,072,947 HEBioT revenue (c) 1,056,875 — Operating expenses - HEBioT (e) 683,647 — Operating expenses - Rental Expenses (f) 137,145 98,148 Operating expenses - Selling, general and administrative (d) (g) 368,700 179,166 Interest expense (h) 242,357 271,498 Debt guarantee fees (j) 67,500 56,250 Cost of revenue, digester inventory or equipment on operating leases acquired — 15,704 (a) Management Advisory Fees - The Company provides management advisory services to Gold Medal Holdings, Inc., a subsidiary of GMG. (b) Project Fees – In addition to Management Advisory Fees, the Company also has provided to GMG subsidiaries non-management advisory services related to projects relating to technology and operations. (c) HEBioT Disposal Revenues – Entsorga West Virginia, LLC has a series of agreements with GMG subsidiaries entities that provide for specified fees for each ton of municipal waste delivered to the HEBioT facility. (d) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International, Inc., a company owned by James Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $200,000 for the term of the License Agreement. Effective October 17, 2018, the agreement was amended to reduce the annual payments to $75,000 and to remove several international locations that the Company does not actively market. (e) Disposal costs – A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility. (f) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of December 31, 2019 under these operating leases total $41,926, which are due in 2020. (g) Business Services Fees – A GMG subsidiary provides certain general management and administrative support to the HEBioT facility. (h) Junior Promissory Note – See Note 13. (i) Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. (j) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. In connection with the line of credit, the Chief Executive Officer and a Director have provided a guarantee of the line of credit in exchange for a fee representing 4.5% of the debt. (k) Consulting Revenue - The Company provided environmental and project consulting to Entsorga West Virginia LLC, an entity that the Company accounted for as an equity investment from March 2017 through December 14, 2018, the date of its control acquisition.

Employee 401(k) Savings Plan

Employee 401(k) Savings Plan	12 Months Ended
	Dec. 31, 2019
Employee 401(k) Savings Plan
Employee 401(k) Savings Plan	Note 21. Employee 401(k) Savings Plan Effective January 1, 2016, the Company established a defined contribution retirement savings plan qualified under Section 401(k) of the Internal Revenue Code. Under the plan, employees may contribute a percentage of eligible compensation on both a before-tax and after-tax basis. The Company may match a percentage of employee’s before-tax contributions, but is not required to do so, as the annual matching contributions are discretionary. No contributions have been made to the plan by the Company during the year ended December 31, 2018.During the year ended December 31, 2019 the Company made contributions of $9,339 to the plan.

Supplemental Consolidated State

Supplemental Consolidated Statement of Cash Flows Information	12 Months Ended
	Dec. 31, 2019
Supplemental Consolidated Statement of Cash Flows Information
Supplemental Consolidated Statement of Cash Flows Information	Note 22. Supplemental Consolidated Statement of Cash Flows Information Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures, are as follows for the years ended December 31: 2019 2018 Changes in operating assets and liabilities: Accounts receivable $ (2,049,366) $ (160,694) Inventory (342,447) (842,944) Prepaid expenses and other assets 4,083 23,019 Accounts payable 3,265,920 333,633 Accrued interest payable 431,001 446,710 Accrued expenses (1,463,398) (982,369) Deferred revenue (11,681) 17,225 Customer deposits 37,109 (31,814) Net change in operating assets and liabilities $ (128,779) $ (1,197,234) Supplementary cash flow information: Cash paid during the periods for: Interest $ 2,775,715 $ 484,259 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 393,795 $ 666,251 Control acquisition of Entsorga West Virginia, LLC with common stock (Note 3) — 1,886,330 Common stock issued in settlement of accrued interest — 915,700 Common stock issued in acquisition of Gold Medal Group, LLC — 2,250,000 Conversion of notes into common stock — 9,090,375 Conversion of Series B preferred stock into common stock — 1,767,371 In-Kind payments by investors for common and preferred stock — 341,998 Exchange of related party notes payable and advances for Series C preferred stock, warrants and notes payable — 5,319,777 Accrual of Series A preferred stock dividends 162,584 85,578 Payment of Series A preferred stock dividends in common stock 200,000 — Conversion of Series A preferred stock into common stock 90,000 533,445 Common stock issued in settlement of accounts payable 205,500 — Reconciliation of Cash and Restricted Cash: Cash $ 1,847,526 $ 2,410,709 Restricted cash (short term) 1,133,581 4,195,148 Restricted cash (non-current) 2,555,845 2,520,523 Total cash and restricted cash at the end of the period $ 5,536,952 $ 9,126,380

Recent Accounting Standards

Recent Accounting Standards	12 Months Ended
	Dec. 31, 2019
Recent Accounting Standards
Recent Accounting Standards	Note 23. Recent Accounting Standards During the year ended December 31, 2019, the Company adopted the following recent accounting standards: In February 2016, the FASB issued new lease accounting guidance (ASU No. 2016‑02, Leases), which has subsequently been amended by ASU No. 2018‑11, Leases in July 2018. Under the new guidance, at the commencement date, lessees will be required to recognize a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new guidance is not applicable for leases with a term of 12 months or less. Lessor accounting is largely unchanged. Public business entities should apply the amendments in ASU 2016‑02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted upon issuance. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. ASU 2018‑11 provides that under certain instances lessors may not be required to separate the components of the contracts. As a lessor of digester equipment under operating leases, the new guidance did not have a material impact on the financial statements. As a lessee under operating leases the adoption did not have a material impact on our financial statements, resulting in an increase of 2% to each of our total assets and total liabilities on our balance sheet, and had an immaterial impact to retained earnings as of the beginning of 2019. See Note 19. In March 2019, the FASB issued ASU 2019-01, Leases (Topic 842, Codification Improvements ), which removed the requirement for an entity to disclose in the interim periods after adoption, the effect of the change on income from continuing operations, net income, any other affected financial statement line item, or per share amount. For lessors, the new leasing standard requires leases to be classified as sales-type, direct financing or operating leases. These criteria focus on the transfer of control of the underlying asset. This standard and related updates were effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2019-01 on January 2019. See Note 15 for disclosures related to this amended guidance. The Company has not yet implemented the following accounting standard: In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments . This standard requires an allowance to be recorded for all expected credit losses for certain financial assets. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. ASU 2016-13 is effective for public companies for interim and annual period beginning December 15, 2020. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company has not yet adopted this update and is currently evaluating the effect this new standard will have on its financial condition and results of operations.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events
Subsequent Events	Note 24. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and globally. The Company is monitoring the outbreak of COVID-19 and the related business and travel restrictions and changes to behavior intended to reduce its spread, and its impact on operations, financial position, cash flows, inventory, supply chains, purchasing trends, customer payments, and the industry in general, in addition to the impact on its employees. Due to the rapid development and fluidity of this situation, the magnitude and duration of the pandemic and its impact on the Company’s operations and liquidity is uncertain as of the date of this report. While there could ultimately be a material impact on operations and liquidity of the Company, at the time of issuance of this annual report on Form 10-K, the impact could not be determined. In mid-March, the Company began migrating to a work-from-home model in compliance with local guidance and as party of an overall cost reduction program, reduced certain staff, primarily related to field services to reduce operating costs. The Company has applied for funds under the Paycheck Protection Program in May 2020 for two of its subsidiaries. The application for these funds requires the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support the ongoing operations of the Company. This certification further requires the Company to take into account its current business activity and its ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. One of the two applications has been approved, amounting to $421,300 and was funded on May 13, 2020. The forgiveness of the loan attendant to these funds, is dependent on the Company qualifying for the forgiveness of such loan based on its future adherence to the forgiveness criteria. The other application in the amount $200,000 has not yet been approved. On January 30, 2020 the Chief Executive Officer and another officer advanced $1,050,000 and $200,000 to the Company, which the Company repaid $275,000 and $200,000 on April 27, 2020, respectively. On March 9, 2020 the Company designated a new series of preferred stock and subsequently on March 18, 2020 had an initial closing of $1,500,000 on 13,045 shares of the new series of preferred stock and 178,597 common stock warrants. This initial closing was followed by an additional closing on April 6, 2020 of $65,000 on 566 shares of the new series of preferred stock and 7,750 common stock warrants. The newly designated series, the Series F Redeemable, Convertible Preferred Stock (the Sr. F Preferred Stock) is comprised of 30,090 shares with a par value of $0.0001 per share and a stated value per share of $115.00 that has a dividend rate of 9%. The Sr. F Preferred Stock is convertible by the holder at any time at a conversion rate of $2.10, subject to certain antidilution adjustments and is redeemable by the Company after 24 months at its stated value, plus any outstanding accrued or accumulated dividends for cash, or if the Company’s common stock is trading over $3.00 per share and has daily trading volume of over 50,000 shares, for the Company’s common stock at the conversion rate in effect at the time. In connection with the offering of the Sr. F Preferred Stock, the Company also issued warrants that expire in five years to acquire the Company’s common stock at $2.30 per share.

Condensed Consolidating Financi

Condensed Consolidating Financial Information	12 Months Ended
	Dec. 31, 2019
Condensed Consolidating Financial Information
Condensed Consolidating Financial Information	Note 25. Condensed Consolidating Financial Information The WVEDA Solid Waste Disposal Revenue Bond obligations of Entsorga West Virginia LLC are not guaranteed by its members, including the Company, however the membership interests of Entsorga West Virginia LLC are pledged, and the debt agreements provide restrictions prohibiting distributions to the members, including equity distributions or providing loans or advances to the members. The following presents the Company’s consolidating balance sheet as of December 31, 2019 and 2018 and its condensed consolidating statement of operations and cash flows for the years ended December 31, 2019 and 2018, for Entsorga West Virginia LLC and the Parent and other Company subsidiaries not subject to the WVEDA Solid Waste Disposal Revenue Bond restrictions and the elimination entries necessary to present the Company’s financial statements on a consolidated basis. These following condensed consolidating financial information should be read in conjunction with the Company’s consolidated financial statements. Condensed Consolidating Balance Sheet as of December 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 1,847,526 $ — $ — $ 1,847,526 Restricted cash — 1,133,581 — 1,133,581 Other current assets 1,697,910 1,116,821 (64,669) 2,750,062 Current assets 3,545,436 2,250,402 (64,669) 5,731,169 Restricted cash — 2,555,845 — 2,555,845 HEBioT facility and other fixed assets 1,753,730 37,392,601 — 39,146,331 Operating lease right of use assets 48,021 897,026 — 945,047 MBT facility development and license costs 6,254,429 1,795,500 — 8,049,929 Investment in subsidiaries 10,864,783 — (10,864,783) — Goodwill — 58,000 — 58,000 Other assets 53,726 — — 53,726 Total assets $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Liabilities and stockholders' equity Line of credit $ 1,479,848 $ — $ — $ 1,479,848 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,387,916 6,475,985 (650,894) 8,213,007 Current liabilities 3,867,764 7,865,985 (650,894) 11,082,855 Notes payable and other debts 5,118,125 — — 5,118,125 Accrued interest 1,510,193 — — 1,510,193 Non-current lease liabilities — 915,170 — 915,170 WV EDA bonds — 29,817,426 — 29,817,426 Total liabilities 10,496,082 38,598,581 (650,894) 48,443,769 Redeemable preferred stock 726,553 — — 726,553 Stockholder's equity: Attributable to parent 2,024,143 — — 2,024,143 Attributable to non-controlling interests 9,273,347 6,350,793 (10,278,558) 5,345,582 Stockholders' equity 11,297,490 6,350,793 (10,278,558) 7,369,725 Total liabilities and stockholders' equity $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Condensed Consolidating Statement of Operations for the year ended December 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 3,108,377 $ 1,111,071 $ — $ 4,219,448 Operating expenses HEBioT — 2,064,139 — 2,064,139 Rental, service and maintenance expense 784,291 — — 784,291 Equipment sales 113,063 — — 113,063 Selling, general and administrative 6,097,817 965,874 — 7,063,691 Depreciation and amortization 495,709 1,233,769 — 1,729,478 Total operating expenses 7,490,880 4,263,782 — 11,754,662 Loss from operations (4,382,503) (3,152,711) — (7,535,214) Other (income) expenses, net 688,621 2,056,226 — 2,744,847 Net loss $ (5,071,124) $ (5,208,937) $ — $ (10,280,061) Condensed Consolidating Statement of Cash Flows for the year ended December 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (5,071,124) $ (5,208,937) $ — $ (10,280,061) Non-cash adjustments to reconcile net loss to net cash used in operations 1,856,795 1,417,445 — 3,274,240 Changes in operating assets and liabilities (1,447,676) 1,318,897 — (128,779) Net cash used in operations (4,662,005) (2,472,595) — (7,134,600) Cash flow used in investing activities: Construction of HEBioT facility and acquisitions of equipment (33,346) (5,077,863) — (5,111,209) Capital contribution to Entsorga West Virginia, LLC (4,586,362) — 4,586,362 — Other investing activities 2,231,824 — — 2,231,824 Net cash used in investing activities (2,387,884) (5,077,863) 4,586,362 (2,879,385) Cash flows from financing activities: Issuances of debt and equity 6,418,057 4,586,362 (4,586,362) 6,418,057 Repayments of debt (9,165) — — (9,165) Deferred financing costs incurred — (62,151) — (62,151) Net cash provided by financing activities 6,408,892 4,524,211 (4,586,362) 6,346,741 Effect of exchange rate on cash 77,816 — — 77,816 Cash - beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash - end of period (restricted and unrestricted) $ 1,847,527 $ 3,689,425 $ — $ 5,536,952 Condensed Consolidating Balance Sheet as of December 31, 2018 Entsorga Parent West and other Virginia Subsidiaries LLC Eliminations Consolidated Assets Cash $ 2,410,709 $ — $ — $ 2,410,709 Restricted cash — 4,195,148 — 4,195,148 Other current assets 969,571 — — 969,571 Current assets 3,380,280 4,195,148 — 7,575,428 Restricted cash — 2,520,523 — 2,520,523 HEBioT facility under construction — 33,104,007 — 33,104,007 Other fixed assets 1,797,915 — — 1,797,915 MBT facility development and license costs 6,585,408 1,890,000 — 8,475,408 Intangible assets, net and investment in subsidiaries 7,626,268 — (5,854,952) 1,771,316 Goodwill — 58,000 — 58,000 Other assets 13,500 — — 13,500 Total assets $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097 Liabilities and stockholders’ equity Line of credit $ 1,469,330 $ — $ — $ 1,469,330 Other current liabilities 2,032,083 3,708,410 — 5,740,493 Current liabilities 3,501,413 3,708,410 — 7,209,823 Notes payable and other debts 4,890,322 — — 4,890,322 Accrued interest 1,305,251 — — 1,305,251 WV EDA bonds — 31,085,902 — 31,085,902 Total liabilities 9,696,986 34,794,312 — 44,491,298 Redeemable preferred stock 816,553 — — 816,553 Stockholder’s equity Attributable to parent 3,405,551 5,854,952 (5,854,952) 3,405,551 Attributable to non-controlling interests 5,484,281 1,118,414 — 6,602,695 Stockholders’ equity 8,889,832 6,973,366 (5,854,952) 10,008,246 Total liabilities and stockholders’ equity $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097 Condensed Consolidating Statement of Operations for the Year Ended December 31, 2018 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 3,359,324 $ — $ — $ 3,359,324 Cost of revenue 1,640,152 — — 1,640,152 Gross profit 1,719,172 — — 1,719,172 Selling, general and administrative 6,677,324 64,237 — 6,741,561 Depreciation and amortization 115,038 — — 115,038 Total operating expenses 6,792,362 64,237 — 6,856,599 Loss from operations (5,073,190) (64,237) — (5,137,427) Other expenses 9,604,528 5,265 — 9,609,793 Net loss $ (14,677,718) $ (69,502) $ — $ (14,747,220) Condensed Consolidating Statement of Cash Flows for the Year Ended December 31, 2018 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows from operating activities: Net loss $ (14,677,718) $ (69,502) $ — $ (14,747,220) Adjustments to reconcile net loss to net cash used in operations 9,900,310 — — 9,900,310 Changes in operating assets and liabilities (528,110) (669,124) — (1,197,234) Net cash used in operations (5,305,518) (738,626) — (6,044,144) Cash flow from investing activities: Cash acquired from control acquisition of Entsorga West Virginia, LLC — 6,773,384 — 6,773,384 Capital contribution to Entsorga West Virginia, LLC (1,000,000) — 1,000,000 — Other investing activities (372,130) (319,086) — (691,216) Net cash used in investing activities (1,372,130) 6,454,298 1,000,000 6,082,168 Cash flows from financing activities: Issuances of debt and preferred stock, net of costs incurred 7,378,869 — — 7,378,869 Repayments of debt (2,472,611) — — (2,472,611) Capital contribution to Entsorga West Virginia, LLC — 1,000,000 (1,000,000) — Cash investment in Refuel America, LLC by non-controlling interest 3,500,000 — — 3,500,000 Other (255,023) — — (255,023) Net cash provided by financing activities 8,151,235 1,000,000 (1,000,000) 8,151,235 Effect of exchange rate on cash 36,009 — — 36,009 Cash – beginning of period 901,112 — — 901,112 Cash – end of period (restricted and unrestricted) $ 2,410,708 $ 6,715,672 $ — $ 9,126,380

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Summary of Significant Accounting Policies
Use of Estimates	Use of Estimates — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, valuation of deferred tax assets, share based compensation, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including intangibles, and useful lives and other provisions and contingencies.
Foreign Operations	Foreign Operations — Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates. Income and expense items are translated at the average rates during the respective periods. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of other comprehensive income (loss) while transaction gains and losses are recorded in net earnings (loss). Deferred taxes are not provided on cumulative foreign currency translation adjustments as the Company presently expects foreign earnings to be permanently reinvested. The Company pays Value Added Tax (“VAT”) or similar taxes (“input VAT”) within the normal course of its business in in the United Kingdom on merchandise and/or services it acquires. The Company also collects VAT or similar taxes on behalf of the government (“output VAT”) for merchandise and/or services it sells. If the output VAT exceeds the input VAT, then the difference is remitted to the government, usually on a monthly basis. If the input VAT exceeds the output VAT, this creates a VAT receivable. The Company either requests a refund of this VAT receivable or applies the balance to expected future VAT payables.
Product and Services Revenue Recognition	Product and Services Revenue Recognition — The Company records revenue based on a five-step model in accordance with ASC 606, Revenue from Contracts with Customers, which require that we: 1. Identify the contract with a customer; 2. Identify the performance obligations in the contract; 3. Determine the transaction price of the contract; 4. Allocate the transaction price to the performance obligations in the contract; 5. Recognize revenue when the performance obligations are met or delivered. When revenue is earned based on product sales, such as sales of digester equipment and parts, solid recovered fuel and recycled materials, the Company’s performance obligations are satisfied at the point in time when products are shipped to the customer, which is when the customer has title and control. Therefore, the Company’s contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of products. When revenue is earned based on receipt of disposal waste, the Company’s performance obligations are satisfied at the point in time when disposal waste products are received from the customer, which is when the Company has title and control. Therefore, the Company’s contracts have a single performance obligation (receipt of disposal waste). When revenue is earned on services, such as management advisory fees and digester maintenance and repair services fees are recognized over the period the services are performed based on service milestones. The adoption of Topic 606 did not have a material impact on the timing or amounts of revenue and costs recognized in the Company’s consolidated financial statements and therefore did not have a material impact on our financial position, results of operations, equity or cash flows as of the adoption date or for the year ended December 31, 2018. The Company did not recognize any cumulative-effect adjustment to retained earnings upon adoption as the impact was immaterial. The Company records taxes collected from customers and remitted to governmental authorities on a net basis.
Lease Revenue Recognition	Lease Revenue Recognition — Rental, service and maintenance revenues relating to the Company’s rental agreements involve providing use of the Company’s digesters at customer locations, access to our software as a service and preventative maintenance over the term. The agreements generally provide for flat monthly payments that the Company believes are consistent with our costs and obligations underlying the agreements. The Company selected the practical expedient not to separate non-lease components from lease components. The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its digester units qualify as operating leases, for which the Company is the operating lessor. In order to determine lease classification as operating, the Company evaluates the terms of the rental agreement to determine if the lease includes any of the following provisions which would indicate sales type lease treatment: · The lease transfers ownership of the underlying asset to the lessee by the end of the lease term, · The lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise, · The Lease term is for the major part of the remaining economic life of the underlying asset. However, if the commencement date falls at or near the end of the economic life of the underlying asset, this criterion shall not be used for purposes of classifying the lease, · The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset or · The underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term.
Restricted Cash	Restricted Cash — Includes Restricted cash that is restricted as to its use, as it is held by a trustee in accordance with the West Virginia Economic Development Authority bond agreement. These amounts are held by the Company’s trustee in various bank accounts segregated for specific uses related to the construction and operation of the resource recovery facility. Amounts required to meet current operations of the Company have been classified as current in the accompanying consolidated balance sheets.
Buildings, Equipment, Fixtures and Vehicles, Including Equipment Leased to Others	Buildings, Equipment, Fixtures and Vehicles, Including Equipment Leased to Others — Buildings, equipment, fixtures and vehicles, including equipment leased to others, is stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the related assets, as follows: Years HEBioT facility 30 HEBiot equipment 15 Equipment leased to others 5 - 7 Computer software and hardware 3 - 5 Vehicles 5 Furniture and fixtures 7 - 15 The Company’s High Efficiency Biological Treatment (“HEBioT”) facility located in West Virginia was under construction through March 31, 2019. Included in the capitalized costs are construction, legal, leasehold improvements, and interest.
MBT Facility Development Costs	MBT Facility Development Costs — The Company defers costs relating to on-going Mechanical Biological Treatment (“MBT”) facility development costs commencing upon the Company’s determination that the project will be completed. These site specific costs generally include external costs generally relating to legal, engineering and other costs relating to the acquisitions of land, permits and licenses. Upon commencement of construction, to the extent that costs relate to the facility, they are transferred to the construction in progress.
Investments in Unconsolidated Entities	Investments in Unconsolidated Entities —The Company has utilized the equity method of accounting for investments in companies if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of net income or loss is included in the Company’s consolidated operations as earning or loss from unconsolidated equity basis investments. In circumstances where the Company does not have the ability to exercise significant influence or control over the operating and financial policies of the investee, the investment is carried at cost, less impairment, adjusted for subsequent changes to estimated fair value up to the original cost.
Long-Lived Assets	Long-Lived Assets — The Company assesses potential impairments to its long-lived assets if events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are reviewed annually for impairment, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. An impaired asset is written down to its estimated fair value based upon the most recent information available. Estimated fair market value is generally measured by discounting estimated future cash flows.
Goodwill	Goodwill — The Company records as goodwill the excess of (i) the consideration transferred, the amount of any non-controlling interest in the acquiree, and the acquisition date fair value of any previous equity interest in the acquired entity over the (ii) fair value of the net identifiable assets acquired. The Company does not amortize goodwill; however, annually, or whenever there is an indication that goodwill may be impaired, qualitative factors are evaluated to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company’s test of goodwill impairment includes assessing qualitative factors and the use of judgment in evaluating economic conditions, industry and market conditions, cost factors, and entity specific events, as well as overall financial performance. Annual goodwill impairment analysis may include, but is not limited to the discounted cash flow method.
Shipping Costs	Shipping Costs — Shipping and handling charges are recorded gross in both the revenue and in cost of revenue and amounted to $96,481 and $100,059 for the years ended December 31, 2019 and 2018, respectively.
Advertising	Advertising — The Company expenses advertising costs as incurred. Advertising expense amounted to $56,742 and $81,901 for the years ended December 31, 2019 and 2018, respectively.
Research and Development	Research and Development — All research and development costs incurred by the Company are expensed as incurred.
Deferred Financing Costs	Deferred Financing Costs — Deferred financing costs relating to issued debt are included as a reduction to the applicable debt and amortized as interest expense over the term of the related debt instruments.
Financial Instruments, Convertible Instruments, Warrants and Derivatives	Financial Instruments, Convertible Instruments, Warrants and Derivatives — The Company reviews its convertible instruments for the existence of embedded conversion features that may require bifurcation. If certain criteria are met, the bifurcated derivative financial instrument is required to be recorded at fair value. The Company also reviews and re-assesses, at each reporting date, any common stock purchase warrants and other freestanding derivative financial instruments and classifies them on the consolidated balance sheet as equity, assets or liabilities based upon the nature of the instruments.
Comprehensive Income (Loss)	Comprehensive Income (Loss) — Comprehensive income (loss) for the Company consists of net earnings (loss) and foreign currency translation.
Income Taxes	Income Taxes — Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
Stock-Based Compensation	Stock-Based Compensation — The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and is estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights. Costs equal to these fair values are recognized as expense ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of the grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in the accompanying consolidated statements of operations based upon the classification of the underlying employees or service providers with a corresponding increase to additional paid in capital. Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.
Loss per Share	Loss per Share — The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” Dividends attributable to preferred stock, whether declared or accrued, and deemed dividends on down round feature are deducted from income attributable to common shareholders for purposes of earnings per share. The Company’s potential dilutive instruments include convertible preferred stock, options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2019
Acquisition and Contribution Agreement
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The estimated fair values of the assets acquired, and the liabilities assumed at the acquisition date are: December 14, 2018 Restricted cash $ 6,773,384 HEBioT facility under construction 32,784,920 MBT license 1,890,000 Total identified assets acquired 41,448,304 Account payable 65,943 Accrued liabilities 4,311,591 Long-term debt 31,085,902 Total liabilities assumed 35,463,436 Identifiable net assets acquired 5,984,868 Goodwill 58,000 Net assets acquired 6,042,868 Less non-controlling interest (3,179,285) Net identifiable assets acquired by Company $ 2,863,583
Schedule of Pro forma information	The following presents unaudited pro forma information as if the acquisition had occurred as of January 1, 2018. The pro forma results do not include any anticipated cost synergies or other effects of the integration of the acquired company. Pro forma amounts are not necessarily indicative of the results that actually would have occurred had the acquisition been completed on the dates indicated, nor is it indicative of future operating results of the combined company. (Unaudited) 2019 2018 Revenue $ 4,219,448 $ 3,359,324 Net loss attributable to Parent (7,622,948) (15,062,634) Proforma earnings per share – basic and diluted (0.56) (1.13)

Accounts Receivable, net (Table

Accounts Receivable, net (Tables)	12 Months Ended
	Dec. 31, 2019
Accounts Receivable, net
Schedule of accounts receivable	Accounts receivable consists of the following as of December 31: 2019 2018 Accounts receivable $ 2,325,959 $ 513,336 Less: allowance for doubtful accounts receivable (170,038) (110,038) $ 2,155,921 $ 403,298
Allowance for doubtful account	Allowance for doubtful accounts activities are as follows for the years ended December 31: 2019 2018 Balance at beginning of year $ (110,038) $ (134,288) Provision for doubtful accounts (103,499) (25,477) Amounts written off 43,499 49,727 Balance at end of year $ (170,038) $ (110,038)

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2019
Inventory
Schedule of inventory	Inventory, comprised of finished goods and parts or assemblies, consist of the following as of December 31: 2019 2018 Equipment $ 119,996 $ 169,540 Parts and assemblies 347,788 330,308 $ 467,784 $ 499,848

Equipment on Operating Leases_2

Equipment on Operating Leases, net (Tables)	12 Months Ended
	Dec. 31, 2019
Equipment on Operating Leases, Net [Abstract]
Schedule of property subject to or available for operating lease	Equipment on operating leases consist of the following as of December 31: 2019 2018 Leased equipment $ 3,138,951 $ 3,054,097 Less: accumulated depreciation (1,413,953) (1,305,210) $ 1,724,998 $ 1,748,887
Schedule Of future minimum rental payments receivable for operating leases	The minimum future estimated contractual payments to be received under these leases as of December 31, 2019 is as follows: Year ending December 31, 2020 $ 1,357,645 2021 984,500 2022 684,095 2023 446,460 2024 and thereafter 127,209 $ 3,599,909

HEBioT Facility, Equipment, F_2

HEBioT Facility, Equipment, Fixtures and Vehicles, net (Tables)	12 Months Ended
	Dec. 31, 2019
HEBioT Facility, Equipment, Fixtures and Vehicles, net
Schedule of HEBioT facility, equipment, fixtures and vehicles	HEBioT facility, equipment, fixtures and vehicles consist of the following as of December 31: 2019 2018 HEBioT facility $ 31,142,974 $ — HEBioT equipment 7,388,896 — Computer software and hardware 112,629 112,500 Furniture and fixtures 48,196 48,196 Vehicles 50,319 50,319 38,743,014 211,015 Less: accumulated depreciation and amortization (1,321,681) (161,987) $ 37,421,333 $ 49,028

MBT Facility Development and _2

MBT Facility Development and License Costs (Tables)	12 Months Ended
	Dec. 31, 2019
MBT Facility Development and License Costs
Schedule of MBT facility development and license costs	MBT Facility Development and License Costs consist of the following as of December 31: 2019 2018 MBT Projects New Windsor, New York: Land acquisition $ — $ 66,000 Legal — 46,030 Survey and engineering — 300,624 — 412,654 Rensselaer, New York: Survey and engineering 235,229 153,554 Total MBT projects 235,229 566,208 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $94,500 of amortization as of December 31, 2019 1,795,500 1,890,000 Total Technology Licenses 7,814,700 7,909,200 Total MBT Facility Development and License Costs $ 8,049,929 $ 8,475,408

Risk Concentrations (Tables)

Risk Concentrations (Tables)	12 Months Ended
	Dec. 31, 2019
Risk Concentrations
Schedule of revenue from external customers by geographic areas	Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2019: Revenue, for the year ended December 31, 2019 $ 3,751,676 $ 467,772 $ 4,219,448 Non-current tangible assets, as of December 31, 2019 38,803,333 355,825 39,159,658 2018: Revenue, for the year ended December 31, 2018 $ 2,952,038 $ 407,286 $ 3,359,324 Non-current tangible assets, as of December 31, 2018 34,630,978 284,444 34,915,422

Line of Credit, Notes Payable_2

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2019
Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt
Schedule of long-term debt	Notes, lines, advances and long-term debts are comprised of the following as of December 31: 2019 2018 Related Related Total Party Total Party Line of credit $ 1,479,848 $ — $ 1,469,330 $ — Senior secured promissory note 4,160,490 — 3,851,305 — Junior promissory note 949,434 949,434 926,211 926,211 Note payable 100,000 — 100,000 — Advance from related party 210,000 210,000 — — Long term debt - current and long-term portion 12,806 — 21,971 —
Schedule of maturities of long-term debts	Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — as of December 31, 2019, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Year Ending December 31, Amortizing Non-Amortizing Total 2020 $ 4,605 $ 100,000 $ 104,605 2021 4,380 1,875,000 1,879,380 2022 3,821 2,500,000 2,503,821 2023 — 625,000 625,000 2024 and thereafter — 1,044,477 1,044,477 Total $ 12,806 $ 6,144,477 $ 6,157,283

Entsorga West Virginia, LLC W_2

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Tables)	12 Months Ended
	Dec. 31, 2019
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Schedule of future sinking fund payments by the borrower	The future sinking fund payments by the Borrower as of December 31, 2019 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2020 $ 1,160,000 $ — $ 230,000 $ 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 965,000 — 300,000 1,265,000 2024 and thereafter 3,295,000 17,465,000 6,940,000 27,700,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000

Equity and Equity Transactions

Equity and Equity Transactions (Tables)	12 Months Ended
	Dec. 31, 2019
Equity and Equity Transactions
Schedule of preferred units	Shares Outstanding Designation Designated Shares Par Value Stated Value December 31, 2019 December 31, 2018 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 145,312 163,312 Series B Convertible Preferred Stock 1,111,200 0.0001 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 100.00 18,850 — Series E Convertible Preferred Stock 714,519 0.0001 2.64 264,519 564,519
Schedule of share-based compensation, activity	Weighted Average Exercises Expiring During the Year Warrant Exercise Price Price Ending December 31, Shares per Share per Share 2020 $ 3.50 $ 3.50 2021 $ 1.80 to $3.30 $ 3.25 2022 $ 1.80 to $5.00 $ 2.60 2023 740,749 $ 1.80 $ 1.80 2024 385,945 $ 1.80 $ 1.80 2025 56,330 $ 2.25 $ 2.25
Schedule of warrants or rights outstanding	Outstanding, January 1, 2019 Issued Issued as a result of common stock offering at $1.80 per share Exercised — Expired — Outstanding, December 31, 2019

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2019
Equity Incentive Plans
Schedule of compensation expenses related to stock options	Compensation expense related to stock options and restricted stock for the years ended December 31, was: 2019 2018 Stock options $ 138,673 $ 164,906 Restricted stock units 960,894 671,466 $ 1,099,567 $ 836,372
Share-based Compensation, Stock Options, Activity [Table Text Block]	The following summarizes the Company’s stock option activity for the year ended December 31, 2019: Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding – January 1, 2019 482,082 3.71 7.80 — Granted — — — — Exercised — — — — Forfeited, Canceled or Expired (118,256) 3.71 — — Outstanding – December 31, 2019 363,826 3.71 7.34 — Exercisable – December 31, 2019 233,475 3.73 6.73 —
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	On June 7, 2018 the Company granted 297,790 non-qualified stock options with an exercise price of $3.68 per share with a total value of $595,563 based upon using the Black-Scholes option pricing model with the following assumptions: Risk-free interest rate % Expected dividend yield % Expected volatility % Expected term in years 6.36
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	The following summarizes the Company’s RSU activity for the years ended December 31, 2019 and 2018: Number of Shares Unvested balance at January 1, 2018 171,112 Granted 768,572 Vested (114,997) Forfeited or Canceled (81,946) Unvested balance at December 31, 2018 742,741 Granted or modified — Vested (410,891) Forfeited or Canceled (40,120) Unvested balance at December 31, 2019 291,730

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Taxes
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	2019 2018 US Federal: Deferred $ 1,664,794 $ 1,992,255 State and local: Deferred 256,238 (618,573) Non-US: Deferred 7,693 58,880 Change in valuation allowance (1,928,725) (1,432,562) Income tax provision $ — $ —
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The reconciliation of differences between the Federal statutory tax rate and the Company’s effective income tax rate for the year ended December 31, was: 2019 2018 U. S. Federal Statutory rate (21.0) % (21.0) % Non-U.S. losses — 0.1 Impact of US statutory tax rate change — — Impact of US statutory tax rate change on valuation allowance — — Local taxes, net of benefit (2.5) 4.2 Nondeductible expenses 5.9 9.6 Other (1.2) (2.6) (18.8) (9.7) Change in valuation allowance 18.8 9.7 Effective income tax rate — % — %
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	The Company’s net deferred tax assets and valuation allowance as of December 31, was: 2019 2018 Deferred tax assets: Net operating losses - Federal $ 6,000,170 $ 3,984,049 Net operating losses - State 1,055,936 802,934 Net operating losses - Non-US 185,556 177,864 Stock-based compensation 649,907 434,487 Accrued expenses 536,348 441,756 Interest — 524,677 Lease liability 212,177 — Other, net 242,793 88,157 8,882,887 6,453,924 Deferred tax liabilities: Property and equipment - Federal (366,413) (86,344) Right of use asset (220,169) — (586,582) (86,344) Net deferred tax assets 8,296,305 6,367,580 Valuation allowance (8,296,305) (6,367,580) Net deferred tax assets $ — $ —

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2019
Leases
Schedule of Maturities of lease liabilities	Year Ending December 31, 2020 $ 146,926 2021 109,000 2022 113,000 2023 113,000 2024 and thereafter 2,980,750 Total lease payments 3,462,676 Less imputed interest (2,401,682) Present value of lease liabilities $ 1,060,994

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2019
Related Party Transactions
Schedule of related party transactions	The face amount of direct related party assets and liabilities and other transactions or conditions as of or for the year ended December 31, was: 2019 2018 Assets: Accounts receivable (a) (b) (c) $ 1,370,867 $ 168,588 Intangible assets, net, included in other assets (d) 40,399 83,933 Liabilities: Accounts payable (d) (e) (f) (g) 2,531,034 160,761 Accrued interest payable 46,796 46,796 Long term accrued interest (h) 1,510,193 1,305,251 Advance from related party (i) 210,000 — Junior promissory note (h) 949,434 926,211 Other: Line of credit guarantee (j) 1,479,848 1,469,330 The table below presents direct related party expenses or transactions for the year ended December 31, 2019. Compensation and related costs for employees of the Company are excluded from the table below. 2019 2018 Management advisory and other fees (a) (b) $ 975,000 $ 1,072,947 HEBioT revenue (c) 1,056,875 — Operating expenses - HEBioT (e) 683,647 — Operating expenses - Rental Expenses (f) 137,145 98,148 Operating expenses - Selling, general and administrative (d) (g) 368,700 179,166 Interest expense (h) 242,357 271,498 Debt guarantee fees (j) 67,500 56,250 Cost of revenue, digester inventory or equipment on operating leases acquired — 15,704 (a) Management Advisory Fees - The Company provides management advisory services to Gold Medal Holdings, Inc., a subsidiary of GMG. (b) Project Fees – In addition to Management Advisory Fees, the Company also has provided to GMG subsidiaries non-management advisory services related to projects relating to technology and operations. (c) HEBioT Disposal Revenues – Entsorga West Virginia, LLC has a series of agreements with GMG subsidiaries entities that provide for specified fees for each ton of municipal waste delivered to the HEBioT facility. (d) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International, Inc., a company owned by James Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $200,000 for the term of the License Agreement. Effective October 17, 2018, the agreement was amended to reduce the annual payments to $75,000 and to remove several international locations that the Company does not actively market. (e) Disposal costs – A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility. (f) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of December 31, 2019 under these operating leases total $41,926, which are due in 2020. (g) Business Services Fees – A GMG subsidiary provides certain general management and administrative support to the HEBioT facility. (h) Junior Promissory Note – See Note 13. (i) Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. (j) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. In connection with the line of credit, the Chief Executive Officer and a Director have provided a guarantee of the line of credit in exchange for a fee representing 4.5% of the debt. Consulting Revenue - The Company provided environmental and project consulting to Entsorga West Virginia LLC, an entity that the Company accounted for as an equity investment from March 2017 through December 14, 2018, the date of its control acquisition

Supplemental Consolidated Sta_2

Supplemental Consolidated Statement of Cash Flows Information (Tables)	12 Months Ended
	Dec. 31, 2019
Supplemental Consolidated Statement of Cash Flows Information
Schedule of supplemental cash flow	Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures, are as follows for the years ended December 31: 2019 2018 Changes in operating assets and liabilities: Accounts receivable $ (2,049,366) $ (160,694) Inventory (342,447) (842,944) Prepaid expenses and other assets 4,083 23,019 Accounts payable 3,265,920 333,633 Accrued interest payable 431,001 446,710 Accrued expenses (1,463,398) (982,369) Deferred revenue (11,681) 17,225 Customer deposits 37,109 (31,814) Net change in operating assets and liabilities $ (128,779) $ (1,197,234) Supplementary cash flow information: Cash paid during the periods for: Interest $ 2,775,715 $ 484,259 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 393,795 $ 666,251 Control acquisition of Entsorga West Virginia, LLC with common stock (Note 3) — 1,886,330 Common stock issued in settlement of accrued interest — 915,700 Common stock issued in acquisition of Gold Medal Group, LLC — 2,250,000 Conversion of notes into common stock — 9,090,375 Conversion of Series B preferred stock into common stock — 1,767,371 In-Kind payments by investors for common and preferred stock — 341,998 Exchange of related party notes payable and advances for Series C preferred stock, warrants and notes payable — 5,319,777 Accrual of Series A preferred stock dividends 162,584 85,578 Payment of Series A preferred stock dividends in common stock 200,000 — Conversion of Series A preferred stock into common stock 90,000 533,445 Common stock issued in settlement of accounts payable 205,500 — Reconciliation of Cash and Restricted Cash: Cash $ 1,847,526 $ 2,410,709 Restricted cash (short term) 1,133,581 4,195,148 Restricted cash (non-current) 2,555,845 2,520,523 Total cash and restricted cash at the end of the period $ 5,536,952 $ 9,126,380

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information (Tables)	12 Months Ended
	Dec. 31, 2019
Condensed Consolidating Financial Information
Schedule of condensed financial statements	Condensed Consolidating Balance Sheet as of December 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 1,847,526 $ — $ — $ 1,847,526 Restricted cash — 1,133,581 — 1,133,581 Other current assets 1,697,910 1,116,821 (64,669) 2,750,062 Current assets 3,545,436 2,250,402 (64,669) 5,731,169 Restricted cash — 2,555,845 — 2,555,845 HEBioT facility and other fixed assets 1,753,730 37,392,601 — 39,146,331 Operating lease right of use assets 48,021 897,026 — 945,047 MBT facility development and license costs 6,254,429 1,795,500 — 8,049,929 Investment in subsidiaries 10,864,783 — (10,864,783) — Goodwill — 58,000 — 58,000 Other assets 53,726 — — 53,726 Total assets $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Liabilities and stockholders' equity Line of credit $ 1,479,848 $ — $ — $ 1,479,848 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,387,916 6,475,985 (650,894) 8,213,007 Current liabilities 3,867,764 7,865,985 (650,894) 11,082,855 Notes payable and other debts 5,118,125 — — 5,118,125 Accrued interest 1,510,193 — — 1,510,193 Non-current lease liabilities — 915,170 — 915,170 WV EDA bonds — 29,817,426 — 29,817,426 Total liabilities 10,496,082 38,598,581 (650,894) 48,443,769 Redeemable preferred stock 726,553 — — 726,553 Stockholder's equity: Attributable to parent 2,024,143 — — 2,024,143 Attributable to non-controlling interests 9,273,347 6,350,793 (10,278,558) 5,345,582 Stockholders' equity 11,297,490 6,350,793 (10,278,558) 7,369,725 Total liabilities and stockholders' equity $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Condensed Consolidating Balance Sheet as of December 31, 2018 Entsorga Parent West and other Virginia Subsidiaries LLC Eliminations Consolidated Assets Cash $ 2,410,709 $ — $ — $ 2,410,709 Restricted cash — 4,195,148 — 4,195,148 Other current assets 969,571 — — 969,571 Current assets 3,380,280 4,195,148 — 7,575,428 Restricted cash — 2,520,523 — 2,520,523 HEBioT facility under construction — 33,104,007 — 33,104,007 Other fixed assets 1,797,915 — — 1,797,915 MBT facility development and license costs 6,585,408 1,890,000 — 8,475,408 Intangible assets, net and investment in subsidiaries 7,626,268 — (5,854,952) 1,771,316 Goodwill — 58,000 — 58,000 Other assets 13,500 — — 13,500 Total assets $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097 Liabilities and stockholders’ equity Line of credit $ 1,469,330 $ — $ — $ 1,469,330 Other current liabilities 2,032,083 3,708,410 — 5,740,493 Current liabilities 3,501,413 3,708,410 — 7,209,823 Notes payable and other debts 4,890,322 — — 4,890,322 Accrued interest 1,305,251 — — 1,305,251 WV EDA bonds — 31,085,902 — 31,085,902 Total liabilities 9,696,986 34,794,312 — 44,491,298 Redeemable preferred stock 816,553 — — 816,553 Stockholder’s equity Attributable to parent 3,405,551 5,854,952 (5,854,952) 3,405,551 Attributable to non-controlling interests 5,484,281 1,118,414 — 6,602,695 Stockholders’ equity 8,889,832 6,973,366 (5,854,952) 10,008,246 Total liabilities and stockholders’ equity $ 19,403,371 $ 41,767,678 $ (5,854,952) $ 55,316,097
Schedule of condensed income statement	Condensed Consolidating Statement of Operations for the year ended December 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 3,108,377 $ 1,111,071 $ — $ 4,219,448 Operating expenses HEBioT — 2,064,139 — 2,064,139 Rental, service and maintenance expense 784,291 — — 784,291 Equipment sales 113,063 — — 113,063 Selling, general and administrative 6,097,817 965,874 — 7,063,691 Depreciation and amortization 495,709 1,233,769 — 1,729,478 Total operating expenses 7,490,880 4,263,782 — 11,754,662 Loss from operations (4,382,503) (3,152,711) — (7,535,214) Other (income) expenses, net 688,621 2,056,226 — 2,744,847 Net loss $ (5,071,124) $ (5,208,937) $ — $ (10,280,061) Condensed Consolidating Statement of Operations for the Year Ended December 31, 2018 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 3,359,324 $ — $ — $ 3,359,324 Cost of revenue 1,640,152 — — 1,640,152 Gross profit 1,719,172 — — 1,719,172 Selling, general and administrative 6,677,324 64,237 — 6,741,561 Depreciation and amortization 115,038 — — 115,038 Total operating expenses 6,792,362 64,237 — 6,856,599 Loss from operations (5,073,190) (64,237) — (5,137,427) Other expenses 9,604,528 5,265 — 9,609,793 Net loss $ (14,677,718) $ (69,502) $ — $ (14,747,220)
Schedule of condensed cash flow Statement	Condensed Consolidating Statement of Cash Flows for the year ended December 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (5,071,124) $ (5,208,937) $ — $ (10,280,061) Non-cash adjustments to reconcile net loss to net cash used in operations 1,856,795 1,417,445 — 3,274,240 Changes in operating assets and liabilities (1,447,676) 1,318,897 — (128,779) Net cash used in operations (4,662,005) (2,472,595) — (7,134,600) Cash flow used in investing activities: Construction of HEBioT facility and acquisitions of equipment (33,346) (5,077,863) — (5,111,209) Capital contribution to Entsorga West Virginia, LLC (4,586,362) — 4,586,362 — Other investing activities 2,231,824 — — 2,231,824 Net cash used in investing activities (2,387,884) (5,077,863) 4,586,362 (2,879,385) Cash flows from financing activities: Issuances of debt and equity 6,418,057 4,586,362 (4,586,362) 6,418,057 Repayments of debt (9,165) — — (9,165) Deferred financing costs incurred — (62,151) — (62,151) Net cash provided by financing activities 6,408,892 4,524,211 (4,586,362) 6,346,741 Effect of exchange rate on cash 77,816 — — 77,816 Cash - beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash - end of period (restricted and unrestricted) $ 1,847,527 $ 3,689,425 $ — $ 5,536,952 Condensed Consolidating Statement of Cash Flows for the Year Ended December 31, 2018 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows from operating activities: Net loss $ (14,677,718) $ (69,502) $ — $ (14,747,220) Adjustments to reconcile net loss to net cash used in operations 9,900,310 — — 9,900,310 Changes in operating assets and liabilities (528,110) (669,124) — (1,197,234) Net cash used in operations (5,305,518) (738,626) — (6,044,144) Cash flow from investing activities: Cash acquired from control acquisition of Entsorga West Virginia, LLC — 6,773,384 — 6,773,384 Capital contribution to Entsorga West Virginia, LLC (1,000,000) — 1,000,000 — Other investing activities (372,130) (319,086) — (691,216) Net cash used in investing activities (1,372,130) 6,454,298 1,000,000 6,082,168 Cash flows from financing activities: Issuances of debt and preferred stock, net of costs incurred 7,378,869 — — 7,378,869 Repayments of debt (2,472,611) — — (2,472,611) Capital contribution to Entsorga West Virginia, LLC — 1,000,000 (1,000,000) — Cash investment in Refuel America, LLC by non-controlling interest 3,500,000 — — 3,500,000 Other (255,023) — — (255,023) Net cash provided by financing activities 8,151,235 1,000,000 (1,000,000) 8,151,235 Effect of exchange rate on cash 36,009 — — 36,009 Cash – beginning of period 901,112 — — 901,112 Cash – end of period (restricted and unrestricted) $ 2,410,708 $ 6,715,672 $ — $ 9,126,380

Basis of Presentation and Goi_2

Basis of Presentation and Going Concern (Details) - USD ($)	May 13, 2020	Dec. 31, 2018	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Basis Of Presentation And Going Concern [Line Items]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ 14,747,220		$ 10,280,061	$ 14,747,220
Operating Income (Loss)		5,137,427		7,535,214	5,137,427
Net Cash Provided by (Used in) Operating Activities		(6,044,144)		(7,134,600)	(6,044,144)
Working Capital Deficit				5,351,686
Proceeds from the issuance of Series F Redeemable, Convertible Preferred Stock and warrants				0	1,125,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		10,008,246		7,369,725	10,008,246
Stockholders' Equity Attributable to Parent		$ 3,405,551		2,024,143	3,405,551	$ (11,016,724)
Application amount approved under paycheck protection program	$ 421,300
Application amount not yet approved under paycheck protection program	200,000
Proceeds from common stock issuance, net of offering costs			$ 3,035,557	$ 3,035,557	$ 0
Refuel America LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage				60.00%
Entsorgia West Virginia LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage		78.20%		88.70%	78.20%
Subsequent events
Basis Of Presentation And Going Concern [Line Items]
Application amount approved under paycheck protection program	421,300
Application amount not yet approved under paycheck protection program	$ 200,000
Series F Redeemable, Convertible Preferred Stock [Member]
Basis Of Presentation And Going Concern [Line Items]
Proceeds from the issuance of Series F Redeemable, Convertible Preferred Stock and warrants				$ 1,565,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Jul. 03, 2019	Dec. 31, 2019	Dec. 31, 2018
Total compensation	$ 2,250,000
Carrying value of investments	1,687,383
Gain on sale of affiliate	$ 562,617	$ 562,617	$ 0
Preferred Units [Member]
Number of stock sold	2,250,000
Class A Common Units [Member]
Number of stock sold	2,250,000
HEBioT facility
Property, Plant and Equipment, Useful Life		30 years
HEBiot equipment
Property, Plant and Equipment, Useful Life		15 years
Equipment Leased to Other Party [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life		7 years
Equipment Leased to Other Party [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life		5 years
Computer Software And Hardware [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life		5 years
Computer Software And Hardware [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life		3 years
Vehicles [Member]
Property, Plant and Equipment, Useful Life		5 years
Furniture and Fixtures [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life		15 years
Furniture and Fixtures [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life		7 years

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Informations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Summary of Significant Accounting Policies
Advertising Expense	$ 56,742	$ 81,901
Cost of revenue	$ 96,481	$ 100,059

Acquisition and Contribution _2

Acquisition and Contribution Agreement - Fair values of the assets acquired and the liabilities (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 14, 2018
Acquisition and Contribution Agreement
Restricted cash			$ 6,773,384
HEBioT facility under construction			32,784,920
MBT license			1,890,000
Total identified assets acquired			41,448,304
Account payable			65,943
Accrued liabilities			4,311,591
Long-term debt			31,085,902
Total liabilities assumed			35,463,436
Identifiable net assets acquired			5,984,868
Goodwill	$ 58,000	$ 58,000	58,000
Net assets acquired			6,042,868
Less non-controlling interest			(3,179,285)
Net identifiable assets acquired by Company			$ 2,863,583

Acquisition and Contribution _3

Acquisition and Contribution Agreement (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Acquisition and Contribution Agreement
Revenue	$ 4,219,448	$ 3,359,324
Net loss attributable to Parent	$ (7,622,948)	$ (15,062,634)
Proforma earnings per share - basic and diluted	$ (0.56)	$ (1.13)

Acquisition and Contribution _4

Acquisition and Contribution Agreement - Additional informations (Details) - USD ($)	Jul. 03, 2019	Dec. 31, 2018	Dec. 14, 2018	Nov. 28, 2018	Dec. 31, 2019	Dec. 31, 2018	Mar. 21, 2017
Royalty Guarantees, Commitments, Amount			$ 6,019,200
Interest Costs Capitalized			316,207
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ (14,747,220)			$ (10,280,061)	$ (14,747,220)
Legal Fees					135,359
Adjusted cost	$ 1,687,383
Revenue					4,219,448	3,359,324
Net loss attributable to Parent					$ (7,622,948)	$ (15,062,634)
Gold Medal Group, LLC [Member]
Cash Contribution			$ 3,500,000
Entsorga West Virginia LLC [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			714,519
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			$ 1,886,630
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination			2,863,583
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value			$ 976,953
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions					4,410.4
Sale of Stock, Number of Shares Issued in Transaction			2,687		2,687	1,723.4
Equity Method Investment, Ownership Percentage					44.10%
Business Acquisition, Percentage of Voting Interests Acquired							17.20%
Number of stock sold			2,687		2,687	1,723.4
Entsorga West Virginia LLC [Member] | Gold Medal Group, LLC [Member]
Equity Method Investment, Ownership Percentage					34.10%
Refuel America LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired			60.00%
Refuel America LLC [Member] | Gold Medal Group, LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired			40.00%
Entsorga USA Inc [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares				714,519
Sale of Stock, Number of Shares Issued in Transaction				2,687
Equity Method Investment, Ownership Percentage			44.10%
Number of stock sold				2,687
Entsorga USA Inc [Member] | Gold Medal Group, LLC [Member]
Equity Method Investment, Ownership Percentage			34.10%
Series E Preferred Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			714,519

Investments in Unconsolidated_2

Investments in Unconsolidated Entities - Additional informations (Details) - USD ($)	Sep. 09, 2019	Jul. 03, 2019	Dec. 14, 2018	Jan. 25, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 13, 2018	Mar. 21, 2017
Stock Issued During Period, Value, New Issues					$ 3,035,557
Stock Issued During Period, Shares, New Issues	1,877,666
Equity Method Investments, Fair Value Disclosure			$ 976,953
Total compensation		$ 2,250,000
Carrying value of investments		1,687,383
Gain on sale of affiliate		$ 562,617			$ 562,617	$ 0
Preferred Units [Member]
Number of stock sold		2,250,000
Class A Common Units [Member]
Number of stock sold		2,250,000
Entsorga West Virginia LLC [Member]
Equity Method Investments								$ 1,034,028
Business Acquisition, Percentage of Voting Interests Acquired								17.20%
Business Acquisition Purchase Price For One Percentage Interest								$ 60,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			714,519
Equity Method Investment, Summarized Financial Information, Net Income (Loss)						$ 193,102
Equity Method Investments, Fair Value Disclosure			$ 823,161
Equity Method Investment Other Income			$ 153,792
Number of stock sold			2,687		2,687	1,723.4
Gold Medal Group, LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired			2.90%	9.20%			9.20%
Business Combination, Consideration Transferred				$ 2,250,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares				500,000
Equity Method Investment, Summarized Financial Information, Net Income (Loss)					$ 562,617
Equity Method Investments, Fair Value Disclosure					$ 2,250,000

Accounts Receivable, net (Detai

Accounts Receivable, net (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Accounts Receivable, net
Accounts receivable	$ 2,325,959	$ 513,336
Less: allowance for doubtful accounts receivable	(170,038)	(110,038)
Accounts Receivable, Net, Current, Total	$ 2,155,921	$ 403,298

Accounts Receivable, net - Allo

Accounts Receivable, net - Allowance for doubtful accounts (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Accounts Receivable, net
Balance at beginning of year	$ (110,038)	$ (134,288)
Provision for doubtful accounts	(103,499)	(25,477)
Amounts written off	43,499	49,727
Balance at end of year	$ (170,038)	$ (110,038)

Inventory (Details)

Inventory (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Inventory [Line Items]
Inventory, Net, Total	$ 467,784	$ 499,848
Equipment [Member]
Inventory [Line Items]
Inventory, Net, Total	119,996	169,540
Parts and assemblies [Member]
Inventory [Line Items]
Inventory, Net, Total	$ 347,788	$ 330,308

Equipment on Operating Leases_3

Equipment on Operating Leases, net (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Less: accumulated depreciation	$ (1,321,681)	$ (161,987)
Property Subject to or Available for Operating Lease, Net, Total	1,724,998	1,748,887
Assets Held under Operating Leases [Member]
Leased equipment	3,138,951	3,054,097
Less: accumulated depreciation	(1,413,953)	(1,305,210)
Property Subject to or Available for Operating Lease, Net, Total	$ 1,724,998	$ 1,748,887

Equipment on Operating Leases_4

Equipment on Operating Leases, net - Minimum Future Estimated Contractual Payments to be Received (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Leases
2020	$ 1,357,645
2021	984,500
2022	684,095
2023	446,460
2024 and thereafter	$ 127,209
Total minimum lease income		$ 3,599,909

Equipment on Operating Leases_5

Equipment on Operating Leases, net - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Leases
Depreciation	$ 431,833	$ 353,189
Operating Leases, Income Statement, Lease Revenue, Total	$ 1,483,852	$ 1,174,772

HEBioT Facility, Equipment, F_3

HEBioT Facility, Equipment, Fixtures and Vehicles, net (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	$ 38,743,014	$ 211,015
Less: accumulated depreciation and amortization	(1,321,681)	(161,987)
Property, Plant and Equipment, Net, Total	37,421,333	49,028
Computer Software And Hardware [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	112,629	112,500
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	48,196	48,196
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	50,319	50,319
HEBioT facility
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	31,142,974	0
HEBiot equipment
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	$ 7,388,896	$ 0

HEBioT Facility, Equipment, F_4

HEBioT Facility, Equipment, Fixtures and Vehicles, net - Additional information (Details) - USD ($)	Dec. 14, 2018	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total		$ 1,729,478	$ 468,227
Interest Costs Capitalized	$ 316,207
HEBioT Facility WV [Member]
Property, Plant and Equipment [Line Items]
Interest Costs Capitalized		618,706
Equipment Fixtures And Vechicles [Member]
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total		20,343	$ 24,838
HEBioT Facility WV [Member]
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total		$ 1,139,269

MBT Facility Development and _3

MBT Facility Development and License Costs (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Land and Land Improvements	$ 8,049,929	$ 8,475,408
New Windsor Site [Member]
Land and Land Improvements	0	412,654
MBT Projects Member [Member]
Land and Land Improvements	235,229	566,208
land Acquisition Costs [Member] | New Windsor Site [Member]
Land and Land Improvements	0	66,000
Legal Cost [Member] | New Windsor Site [Member]
Land and Land Improvements	0	46,030
Survey and Engineering Costs [Member] | New Windsor Site [Member]
Land and Land Improvements	0	300,624
Survey and Engineering Costs [Member] | Rensselaer [Member]
Land and Land Improvements	235,229	153,554
Technology Licenses Cost [Member]
Land and Land Improvements	7,814,700	7,909,200
Technology Licenses Cost [Member] | Future Site [Member]
Land and Land Improvements	6,019,200	6,019,200
Technology Licenses Cost [Member] | Martinsburg West Virginia [Member]
Land and Land Improvements	1,795,500	1,890,000
Facility Development And License Cost [Member]
Land and Land Improvements	$ 8,049,929	$ 8,475,408

MBT Facility Development and _4

MBT Facility Development and License Costs - Additional Information (Details)	Sep. 09, 2019$ / sharesshares	Feb. 28, 2019USD ($)	Dec. 14, 2018USD ($)$ / shares	Nov. 01, 2017t	Dec. 31, 2019USD ($)$ / shares	Dec. 31, 2018$ / shares
Royalty Guarantees, Commitments, Amount			$ 6,019,200
Stock Issued During Period, Shares, New Issues | shares	1,877,666
Payments to Acquire Property, Plant, and Equipment					$ 5,111,209
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001		$ 0.0001		$ 0.0001	$ 0.0001
Biological Treatment Waste Capacity | t				165,000
Payments For Rescinded Contract		$ 66,000
Intellectual Property [Member] | Entsorgafin S.p.A [Member]
Royalty Guarantees, Commitments, Amount			$ 6,019,200
Lease Agreements [Member]
Finite-lived Intangible Assets Acquired			$ 1,890,000
Land [Member] | Lease Agreements [Member]
Amortization Expenses					$ 94,500
Selling, General and Administrative Expenses [Member] | Land [Member]
Asset Impairment Charges		$ 346,654

Intangibles Assets, net (Detail

Intangibles Assets, net (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Intangibles Assets, net
Other Intangible Assets, Net	$ 40,399	$ 83,933
Amortization of Intangible Assets	$ 43,533	$ 90,200

Goodwill - Additional Informati

Goodwill - Additional Information (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 14, 2018
Goodwill
Goodwill.	$ 58,000	$ 58,000	$ 58,000

Risk Concentrations (Details)

Risk Concentrations (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Concentration Risk [Line Items]
Revenue	$ 3,359,324	$ 4,219,448	$ 3,359,324	$ 3,359,324
Non-current tangible assets	34,915,422	39,159,658	34,915,422
United States [Member]
Concentration Risk [Line Items]
Revenue		3,751,676		2,952,038
Non-current tangible assets	34,630,978	38,803,333	34,630,978
International [Member]
Concentration Risk [Line Items]
Revenue		467,772		$ 407,286
Non-current tangible assets	$ 284,444	$ 355,825	$ 284,444

Risk Concentrations - Additiona

Risk Concentrations - Additional Information (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Gold Medal Group [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	40.00%
Sales Revenue, Net [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	48.20%
Sales Revenue, Net [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	30.70%
Sales Revenue, Net [Member] | Major Customer [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	10.00%
Accounts Receivable [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	58.90%	32.80%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10.00%
Accounts Payable [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		1.40%
Accounts Payable [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	0.00%
Accounts Payable [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	12.00%
Cost Of Revenue [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		11.00%
Cost Of Revenue [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		1.40%
Cost Of Revenue [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	23.10%
Cost Of Revenue [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	25.10%
Cost Of Revenue [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10.00%

Line of Credit, Notes Payable_3

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt (Details) - USD ($)		Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Line of credit carrying value as of the balance sheet		$ 1,479,848	$ 1,469,330
Senior secured promissory note		4,160,490	3,851,305
Junior promissory note		949,434	926,211
Notes payable		100,000	100,000
Advance from related party		210,000	0
Long term debt - current and long-term portion		12,806	21,971
Related Party [Member]
Debt Instrument [Line Items]
Line of credit carrying value as of the balance sheet		0	0
Senior secured promissory note		0	0
Junior promissory note		949,434	926,211
Notes payable		0	0
Advance from related party	[1]	210,000	0
Long term debt - current and long-term portion		$ 0	$ 0
[1]	Disposal costs - A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility.Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of December 31, 2019 under these operating leases total $41,926, which are due in 2020.Business Services Fees - A GMG subsidiary provides certain general management and administrative support to the HEBioT facility.Junior Promissory Note - See Note 13.Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.

Line of Credit, Notes Payable_4

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt - Maturities of Long Term Debts (Details)	Dec. 31, 2019USD ($)
2020	$ 104,605
2021	1,879,380
2022	2,503,821
2023	625,000
2024 and thereafter	1,044,477
Total	6,157,283
Amortizing [Member]
2020	4,605
2021	4,380
2022	3,821
2023	0
2024 and thereafter	0
Total	12,806
Non-Amortizing [Member]
2020	100,000
2021	1,875,000
2022	2,500,000
2023	625,000
2024 and thereafter	1,044,477
Total	$ 6,144,477

Line of Credit, Notes Payable_5

Line of Credit, Notes Payable, Advances, Promissory Note and Long-Term Debt - Additional Information (Details) - USD ($)	Feb. 11, 2019	Nov. 09, 2018	Feb. 02, 2018	Dec. 31, 2019	Dec. 31, 2018	Sep. 09, 2019	Dec. 14, 2018	Mar. 23, 2018
Debt Instruments of face values issue				$ 33,000,000	$ 33,000,000
Warrants issued				56,330
Amortization of Debt Issuance Costs				$ 415,185	231,510
Line of credit carrying value as of the balance sheet				$ 1,479,848	1,469,330
Value issued during the period for debt financings					$ 1,212,121
Preferred Stock, par value (in dollars per share)				$ 0.0001	$ 0.0001
Common stock, par value				$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Junior promissory note				$ 949,434	$ 926,211
Credit facility amount increases		$ 1,500,000
Securities Exchange and Note Purchase Agreement [Member]
Warrants issued			421,053
Comerica Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 1,000,000
Effective interest rate				5.71%	6.52%
Amortization of Debt Issuance Costs				$ 14,796	$ 4,278
Variable Interest rate on the debt instrument				3.00%
Expiration date of line of credit facility				Jan. 1, 2020
Line of credit carrying value as of the balance sheet				$ 1,500,000	1,500,000
Debt issuance costs				34,948	34,948
Unsecured Promissory Notes One [Member]
Debt Instruments of face values issue			4,500,000
Miichaelson Senior Secured Term Promissory [Member]
Debt Instruments of face values issue			$ 5,000,000	$ 5,000,000
Interest rate of stated percentage			10.25%
Maturity date of debt instruments				Feb. 2, 2023
Unamortized discount non current				$ 485,878	223,443
Amortization of Debt Issuance Costs				97,920	51,170
Debt issuance costs				211,187
Share issued for debt financings			320,000
Value issued during the period for debt financings				1,212,121
Principal installments payment			$ 625,000
Junior Promissory Note [Member]
Amortization of Debt Issuance Costs				$ 40,780	17,557
Junior promissory note			1,044,477
Carried net of discounts			135,823
Maximum [Member]
Effective interest rate				4.99%
Minimum [Member]
Effective interest rate				1.90%
Unsecured Debt [Member]
Debt Instruments of face values issue				$ 100,000	$ 100,000
Interest rate of stated percentage				10.00%	10.00%
Maturity date of debt instruments				Jan. 1, 2020
Notes Payable [Member] | Securities Exchange and Note Purchase Agreement [Member]
Original debt conversion			4,500,000
Series D Convertible Notes and Warrants [Member]
Conversion Price	$ 3.50
Divident rate of preferred stock	9.00%
Series C Preferred Stock [Member]
Debt Instruments of face values issue			544,777
Original debt conversion			$ 4,000,000
Preferred Stock, par value (in dollars per share)			$ 0.0001	$ 0.0001
Share issued (per share)								$ 10
Divident rate of preferred stock				10.25%

Entsorga West Virginia, LLC W_3

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Details)	12 Months Ended
	Dec. 31, 2019USD ($)
Debt Instrument, Sinking Fund Payment	$ 33,000,000
Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	1,390,000
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	1,470,000
Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	1,175,000
Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	1,265,000
Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	27,700,000
2016 Issue 2026 Series [Member]
Debt Instrument, Sinking Fund Payment	7,535,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	1,160,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	1,215,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	900,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	965,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	3,295,000
2016 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	17,465,000
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	17,465,000
2018 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	8,000,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	230,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	255,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	275,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	300,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	$ 6,940,000

Entsorga West Virginia, LLC W_4

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2016	Nov. 01, 2018
Debt Instruments of face values issue	$ 33,000,000	$ 33,000,000
Unamortized Debt Issuance Expense	2,207,759	2,145,608
Amortization of Debt Issuance Costs	415,185	$ 231,510
Financial Standby Letter of Credit [Member]
Collateral Amount				$ 1,250,000
WVEDA Bonds [Member]
Debt Instruments of face values issue			$ 25,000,000
Series One [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue			$ 7,535,000
Interest rate of stated percentage			6.75%
Maturity date of debt instruments			Feb. 1, 2026
Series Two [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue			$ 17,465,000
Interest rate of stated percentage			7.25%
Maturity date of debt instruments			Feb. 1, 2036
Series Three [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue	$ 8,000,000
Interest rate of stated percentage	8.75%
Maturity date of debt instruments	Feb. 1, 2036

Equity and Equity Transaction_2

Equity and Equity Transactions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Preferred stock,Authorized shares	3,179,120	3,159,120
Preferred Stock, Shares Outstanding		1,155,331
Series A Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	333,401
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	145,312	163,312
Series B Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	1,111,200
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	1,000,000	1,000,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 10
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	20,000	20,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 100
Preferred Stock, Shares Outstanding	18,850	18,850
Series E Convertible Preferred Stock [Member]
Preferred stock,Authorized shares	714,519	714,519
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 2.64
Preferred Stock, Shares Outstanding	264,519	564,519

Equity and Equity Transaction_3

Equity and Equity Transactions - Warrants (Details) - $ / shares	Dec. 31, 2019	Sep. 09, 2019	Dec. 31, 2018	Mar. 30, 2018
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.25	$ 1.80		$ 5
Class of Warrant or Right, Outstanding	4,674,261		4,201,736
2020
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 3.50
Class of Warrant or Right, Outstanding	22,860
Weighted Average Price per Share	$ 3.50
2021
Class of Warrant or Right, Outstanding	1,768,516
Weighted Average Price per Share	$ 3.25
2022
Class of Warrant or Right, Outstanding	1,699,861
Weighted Average Price per Share	$ 2.60
2023
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Class of Warrant or Right, Outstanding	740,749
Weighted Average Price per Share	$ 1.80
2024
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Class of Warrant or Right, Outstanding	385,945
Weighted Average Price per Share	$ 1.80
2025
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.25
Class of Warrant or Right, Outstanding	56,330
Weighted Average Price per Share	$ 2.25
Maximum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	3.30
Maximum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	5
Minimum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	1.80
Minimum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80

Equity and Equity Transaction_4

Equity and Equity Transactions - Outstanding Warrant Activity (Details)	12 Months Ended
	Dec. 31, 2019shares
Equity and Equity Transactions
Outstanding Beginning Balance	4,201,736
Issued	442,275
Issued as a result of common stock offering at $1.80 per share	30,250
Exercised	0
Expired	0
Outstanding Ending Balance	4,674,261

Equity and Equity Transaction_5

Equity and Equity Transactions - Additional Information (Details)	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 16, 2019USD ($)$ / sharesshares	Dec. 02, 2019USD ($)$ / sharesshares	Nov. 14, 2019USD ($)$ / sharesshares	Nov. 04, 2019USD ($)$ / sharesshares	Sep. 26, 2019USD ($)$ / sharesshares	Sep. 09, 2019USD ($)$ / sharesshares	Mar. 30, 2019USD ($)	Feb. 11, 2019USD ($)$ / shares	Dec. 31, 2018USD ($)$ / sharesshares	Feb. 02, 2018USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Sep. 30, 2019USD ($)	Oct. 31, 2018USD ($)shares	Aug. 31, 2018USD ($)shares	Jun. 30, 2018USD ($)shares	Mar. 23, 2018USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 14, 2018$ / sharesshares	Mar. 30, 2018$ / shares	Feb. 10, 2016$ / shares
Common Stock, Shares Authorized | shares	50,000,000									50,000,000		50,000,000						50,000,000	50,000,000
Common stock, par value | $ / shares	$ 0.0001						$ 0.0001			$ 0.0001		$ 0.0001						$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized | shares	10,000,000									10,000,000		10,000,000						10,000,000	10,000,000
Common Stock, Shares, Issued | shares	17,300,899									14,802,956		17,300,899						17,300,899	14,802,956
Preferred stock, Designated shares | shares	3,179,120									3,159,120		3,179,120						3,179,120	3,159,120
Dividends Payable	$ 1,042,287											$ 1,042,287						$ 1,042,287
Description of Equity Method Investment Ownbership Percentage																		The consolidated financial statements include less than 100% owned and controlled subsidiaries
Equity Method Investment, Description of Principal Activities																		include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries
Issuance of registered common shares, net of offering costs (in shares) | shares							1,877,666
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 2.25						$ 1.80					$ 2.25						$ 2.25			$ 5
Gross proceeds of the offering																		$ 3,379,799
Placement fees																		195,461
Legal fees																		135,359
Regulatory filing fees																		8,000
Other costs																		5,422
Net proceeds of the offering													$ 3,035,557					$ 3,035,557	$ 0
Warrants issued | shares	56,330											56,330						56,330
Exercise price of warrants | $ / shares	$ 2.25						$ 1.80					$ 2.25						$ 2.25			$ 5
Payments for Repurchase of Preferred Stock and Preference Stock								$ 317,000										$ 0	317,000
Additional Interest expense to write of unamortized discounts and costs relating to shares redeemed								157,455
Number of shares converted | shares														20,000	46,689
Stock Issued During Period, Value, Conversion of Units														$ 100,000	$ 233,445	$ 200,000
Stock Issued During Period, Shares, Conversion of Units | shares														22,222	51,876
Additional Interest expense to write of unamortized discounts and costs relating to shares converted															$ 47,767	$ 73,461
Preferred Stock, Value, Issued
Preferred stock, stated value	$ 726,553									$ 816,553		$ 726,553						$ 726,553	816,553
Amortization of Discounts on Preferred Stock																			$ 1,043,715
Conversion of Series A preferred stock into common stock | shares	90,000						50,000			533,445		90,000						90,000	533,445	714,539
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001									$ 0.0001		$ 0.0001						$ 0.0001	$ 0.0001
Preferred stock, voting rights																		non-redeemable, has voting rights together with the common stock, par $0.0001, at the rate of 4 votes to 1
Debt Conversion, Converted Instrument, Amount	$ 0									$ 9,090,375
Debt Instrument, Face Amount	$ 33,000,000									$ 33,000,000		$ 33,000,000						$ 33,000,000	$ 33,000,000
Class of Warrant or Right, Outstanding | shares	4,674,261									4,201,736		4,674,261						4,674,261	4,201,736
Preferred Stock, Value, Subscriptions	$ 1,885,000											$ 1,885,000						$ 1,885,000
Class of Warrant or Right Percentage of Securities Called by Each Warrant or Right																		50.00%
Class of Warrant or Right | shares	4,674,261									4,201,736		4,674,261						4,674,261	4,201,736
Risk-free Interest Rate																		2.81%
Warrants modification							$ 49,160											$ 49,160	$ 0
Value of warrants after revaluation							$ 405,324
Preferred Stock, Shares Outstanding | shares										1,155,331									1,155,331
Volatility
Warrants, measurement input							50.56
Risk free rate
Warrants, measurement input							1.51
Securities Exchange and Note Purchase Agreement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares											$ 10.25
Warrants issued | shares											421,053
Exercise price of warrants | $ / shares											$ 10.25
class of warrant or right, expiration period											5 years
Notes Payable [Member]
Warrants issued | shares											421,053
Confidentially marketed public offering
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 1.80						$ 1.80					$ 1.80						$ 1.80
Warrants issued | shares							1,992,325
Exercise price of warrants | $ / shares	$ 1.80						$ 1.80					$ 1.80						$ 1.80
Series D Convertible Notes and Warrants [Member]
Preferred Stock, Dividend Rate, Percentage									9.00%
Preferred Stock, Stated Value									$ 100
Debt Instrument, Convertible, Conversion Price | $ / shares									$ 3.50
Warrants [Member]
Warrants issued | shares	116,651											116,651						116,651
Maxim Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares																						$ 4,674,261
Exercise price of warrants | $ / shares																						$ 4,674,261
Common Stock [Member]
Issuance of registered common shares, net of offering costs (in shares) | shares																		1,877,666
Common Stock issued for accrued dividends (in shares) | shares																		111,111
Series D Convertible Preferred Stock [Member]
Preferred stock, Designated shares | shares	20,000									20,000		20,000						20,000	20,000
Issuance of registered common shares, net of offering costs (in shares) | shares																		18,850
Preferred Stock, Value, Issued	$ 1,505,262											$ 1,505,262						$ 1,505,262
Preferred Stock, Shares Outstanding | shares	18,850									18,850		18,850						18,850	18,850
Series D Convertible Preferred Stock [Member] | Five Year Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 3.50											$ 3.50						$ 3.50
Exercise price of warrants | $ / shares	$ 3.50											$ 3.50						$ 3.50
Class of Warrant or Right, Outstanding | shares	269,296											269,296						269,296
Class of Warrant or Right | shares	269,296											269,296						269,296
Stock Price, Maximum | $ / shares																		$ 2.70
Stock Price, Minimum | $ / shares																		$ 1.88
Standard Deviation Volatility, Maximum																		44.55%
Standard Deviation Volatility, Minimum																		46.38%
Risk-free Interest Rate, Maximum																		1.74%
Risk-free Interest Rate, Minimum																		2.56%
Allocated Fair value Of the Warrant																		$ 190,299
Series D Convertible Preferred Stock [Member] | Warrants [Member]
Standard Deviation Volatility, Maximum																		46.23%
Series A preferred stock [Member]
Common stock, par value | $ / shares		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Dividends Payable	$ 56,886											$ 56,886						$ 56,886
Warrants issued | shares	180,000											180,000						180,000
Share price | $ / shares	$ 4.05											$ 4.05						$ 4.05
Fair Values Assumptions Exercise Price | $ / shares	$ 5											$ 5						$ 5
Fair values assumptions expected volatility rate																		41.80%
Number of shares converted | shares							18,000									40,000
Stock Issued During Period, Value, Conversion of Units																		$ 90,000	$ 533,445
Preferred Stock, Value, Issued	$ 816,553											$ 816,553						816,553
Preferred stock, stated value	726,553											726,553						726,553
Preferred Stock, Original Issue Discount																			166,699
Warrants and rights outstanding										$ 403,630									403,630
Convertible preferred stock, beneficial conversion feature																		535,630
Preferred Stock, Issuance Costs, Gross	$ 30,000											30,000						$ 30,000
Value of shares issued for payment of accrued dividend		$ 15,000	$ 35,000	$ 50,000	$ 50,000	$ 50,000						$ 145,312
Common Stock issued for accrued dividends (in shares) | shares		8,333	19,444	27,778	27,778	27,778
Fair values assumptions risk free interest rate																		2.90%
Preferred Stock, Shares Outstanding | shares	163,312											163,312						163,312
Series A preferred stock [Member] | Common Stock [Member]
Stock Issued During Period, Value, Conversion of Units																		$ 5	$ 11
Stock Issued During Period, Shares, Conversion of Units | shares																44,444		50,000	118,542
Series C Preferred Stock [Member]
Convertible preferred stock, beneficial conversion feature																		$ 668,575
Shares Issued, Price Per Share | $ / shares																	$ 10
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001										$ 0.0001	$ 0.0001						$ 0.0001
Preferred Stock, Dividend Rate, Percentage																		10.25%
Debt Conversion, Original Debt, Amount											$ 4,000,000
Debt Instrument, Face Amount											$ 544,777
Series C Preferred Stock [Member] | Securities Exchange and Note Purchase Agreement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares											$ 5.50
Exercise price of warrants | $ / shares											5.50
Series C Convertible Preferred Stock [Member]
Preferred stock, Designated shares | shares	1,000,000									1,000,000		1,000,000						1,000,000	1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares																	$ 5.50
Warrants issued | shares																	28,948
Exercise price of warrants | $ / shares																	$ 5.50
Share price | $ / shares											4.95						4.05
Fair Values Assumptions Exercise Price | $ / shares											$ 5.50						$ 5.50
Fair values assumptions expected volatility rate											40.48%						41.77%
Preferred Stock, Value, Issued	$ 3,050,142									$ 3,050,142		$ 3,050,142						$ 3,050,142	$ 3,050,142
Warrants and rights outstanding	556,283											556,283						$ 556,283
Preferred Stock, Dividend Rate, Percentage																		10.25%
Preferred stock, value, outstanding	$ 4,275,000											$ 4,275,000						$ 4,275,000
Debt Conversion, Original Debt, Amount																	$ 275,000
Debt Conversion, Converted Instrument, Amount																	$ 275,000
Warrant expiration terms																	5 years
Fair values assumptions risk free interest rate											2.95%						2.91%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 4.75											$ 4.75						$ 4.75
Fair values assumptions expected term											5 years						5 years
Preferred Stock, Shares Outstanding | shares	427,500									427,500		427,500						427,500	427,500
Series C Convertible Preferred Stock [Member] | Securities Exchange and Note Purchase Agreement [Member]
Debt Instrument, Maturity Date											Feb. 2, 2024
Series A Redeemable Convertible Preferred Stock [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 4.50											$ 4.50						$ 4.50
Exercise price of warrants | $ / shares	$ 4.50											$ 4.50						$ 4.50
Class of warrant or right, number of securities called by each warrant or right | shares	180,000											180,000						180,000
Fair values assumptions expected term																		4 years
Interest expense, other								$ 246,319
Series E Preferred Stock [Member]
Common stock, par value | $ / shares	$ 0.0001											$ 0.0001						$ 0.0001
Number of shares converted | shares																		150,000
Conversion of Series A preferred stock into common stock | shares	150,000											150,000						150,000
Shares Issued, Price Per Share | $ / shares	$ 2.64											$ 2.64						$ 2.64
Preferred Stock, Par or Stated Value Per Share | $ / shares																				$ 0.0001
Series E Preferred Stock [Member] | Common Stock [Member]
Issuance of registered common shares, net of offering costs (in shares) | shares																		300,000

Equity Incentive Plans - Compen

Equity Incentive Plans - Compensation Expenses Related to Stock Options (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Equity Incentive Plans
Stock options	$ 138,673	$ 164,906
Restricted stock	960,894	671,466
Total	$ 1,099,567	$ 836,372

Equity Incentive Plans - Stock

Equity Incentive Plans - Stock option activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Aggregate Intrinsic Value, Balance	$ 0
Aggregate Intrinsic Value, Exercisable	$ 0
Employee Stock Option [Member]
Number of options, Beginning Balance	482,082
Number of Options, Forfeited or Canceled	(118,256)
Number of Options, Ending Balance	363,826	482,082
Number of Options, Exercisable, Ending Balance	233,475
Weighted Average Exercise Price, Beginning Balance	$ 3.71
Weighted Average Exercise Price, Forfeited or Canceled	3.71
Weighted Average Exercise Price, Ending Balance	$ 3.71	$ 3.71
Weighted Average Remaining Contractual Life (in Years), Outstanding	7 years 4 months 2 days	7 years 9 months 18 days
Weighted Average Remaining Contractual Life (in Years), Exercisable	6 years 8 months 23 days
Weighted Average Exercise Price, Exercisable	$ 3.73

Equity Incentive Plans - Black-

Equity Incentive Plans - Black-Scholes option pricing model (Details)	12 Months Ended
	Dec. 31, 2019
Equity Incentive Plans
Risk-free interest rate	2.81%
Expected dividend yield	0.00%
Expected volatility	53.35%
Expected term in years	6 years 4 months 10 days

Equity Incentive Plans - Schedu

Equity Incentive Plans - Schedule of Restricted Stock (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Equity Incentive Plans
Unvested balance at beginning	742,741	171,112
Grants	0	768,572
Vested	(410,891)	(114,997)
Forfeited or Canceled	(40,120)	(81,946)
Unvested balance at end	291,730	742,741

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 07, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		0	768,572
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 159,657	$ 462,297
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		1 year 9 months 7 days	2 years 5 months 9 days
Share based Compensation Non Qualified Stock Options Granted in the period	297,790
Share based Compensation Non Qualified Stock Options Exercise Price	$ 3.68
Share based Compensation Non Qualified Stock Option Carrying value	$ 595,563
Capital Units, Authorized	1,750,000
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			768,572
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested		$ 495,941	$ 1,203,240
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 766,555	$ 1,884,479
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		1 year 5 months 5 days	2 years 4 months 2 days
Sharebased Compensation Arrangement by Sharebased Payment Award Equity Instruments Other than Options Grants in Period Fair Value			$ 2,472,246
Restricted Stock Units (RSUs) [Member] | Minimum [Member]
Share Price		$ 3.50
Restricted Stock Units (RSUs) [Member] | Maximum [Member]
Share Price		$ 4.05
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized				750,000
Executive Incentive Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized				1,000,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
US Federal:
Deferred	$ 1,664,794	$ 1,992,255
State and local:
Deferred	256,238	(618,573)
Non-US:
Deferred	7,693	58,880
Change in valuation allowance	(1,928,725)	(1,432,562)
Income tax provision	$ 0	$ 0

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Taxes
U. S. Federal Statutory rate	(21.00%)	(21.00%)
Non-U.S. losses	0.00%	0.10%
Impact of US statutory tax rate change	0.00%	0.00%
Impact of US statutory tax rate change on valuation allowance	0.00%	0.00%
Local taxes, net of benefit	(2.50%)	4.20%
Nondeductible expenses	5.90%	9.60%
Other	(1.20%)	(2.60%)
Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent	(18.80%)	(9.70%)
Change in valuation allowance	18.80%	9.70%
Effective income tax rate	0.00%	0.00%

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Deferred tax assets:
Net operating losses - Federal	$ 6,000,170	$ 3,984,049
Net operating losses - State	1,055,936	802,934
Net operating losses - Non-US	185,556	177,864
Stock-based compensation	649,907	434,487
Accrued expenses	536,348	441,756
Interest	0	524,677
Lease liability	212,177	0
Other, net	242,793	88,157
Deferred Tax Assets, Operating Loss Carryforwards, Total	8,882,887	6,453,924
Deferred tax liabilities:
Property and equipment - Federal	(366,413)	(86,344)
Right of use assets.	(220,169)	0
Deferred Tax Assets, Gross, Total	(586,582)	(86,344)
Net deferred tax assets	8,296,305	6,367,580
Valuation allowance	(8,296,305)	(6,367,580)
Net deferred tax assets	$ 0	$ 0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	Dec. 31, 2019USD ($)
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration	$ 14,200,000
Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration	14,372,000
Domestic Tax Authority [Member]
Operating Loss Carryforwards	28,572,000
State and Local Jurisdiction [Member]
Operating Loss Carryforwards	$ 14,325,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)	Mar. 12, 2020	Dec. 31, 2019	Dec. 31, 2019
Stock Issued During Period, Shares, Other		75,000
Settled litigation - Litigation for alleged breach of contract and unjust enrichment on the company's resource recovery facility | Subsequent events
Total amount payable	$ 775,000
Amount payable on the execution of the settlement agreement	$ 475,000
Execution period for the settlement agreement	60 days
Amount payable as monthly installments	$ 25,000
Number of installment months	12 months
Consulting Services Related Matters [Member] | Tusk Ventures LLC [Member]
Loss Contingency, Damages Sought, Value			$ 250,000

Leases (Details)

Leases (Details)	Dec. 31, 2019USD ($)
Leases
2020	$ 146,926
2021	109,000
2022	113,000
2023	113,000
2024 and thereafter	2,980,750
Total lease payments	3,462,676
Less imputed interest	(2,401,682)
Present value of lease liabilities	$ 1,060,994

Leases - Additional Information

Leases - Additional Information (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Lessee, Lease, Description [Line Items]
Operating Lease Renewal Term	5 years		5 years
Operating Leases, Rent Expense			$ 683,647	$ 0
Operating Lease, Liability, Current	$ 146,926		$ 146,926
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued Expenses and Other Current Liabilities		Accrued Expenses and Other Current Liabilities
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 1,045,755
Operating Lease, Payments	$ 195,003
Land Lease [Member]
Lessee, Lease, Description [Line Items]
Operating Lease Initial Term	30 years		30 years
Leases Utilization Percentage	11.00%
Other Lease [Member]
Lessee, Lease, Description [Line Items]
Leases Utilization Percentage	10.25%
Research And Development Lease [Member]
Lessee, Lease, Description [Line Items]
Operating Leases, Rent Expense	$ 221,423	$ 155,060
Operating Lease, Weighted Average Remaining Lease Term	25 years 3 months 18 days		25 years 3 months 18 days

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Assets:
Accounts receivable		$ 403,298	$ 2,155,921	$ 403,298
Intangible assets, net, included in other assets			945,047
Liabilities:
Accounts payable (related entity $2,531,034 and $160,761 as of December 31, 2019 and 2018, respectively)		1,310,998	4,688,339	1,310,998
Accrued interest payable		959,927	1,148,570	959,927
Long term accrued interest		1,305,251	1,510,193	1,305,251
Advance from related party		0	210,000	0
Other:
HEBioT revenue	[1]		1,056,875	0
Operating expenses - HEBioT			683,647	0
Operating expenses - Rental Expenses			137,145	98,148
Operating expenses - Selling, general and administrative		1,640,152
Interest expense			242,357	271,498
Cost of revenue, inventory or equipment on operating leases acquired	[2]		0	15,704
Related Party [Member]
Assets:
Accounts receivable	[1]	168,588	1,370,867	168,588
Intangible assets, net, included in other assets	[2]	83,933	40,399	83,933
Liabilities:
Accounts payable (related entity $2,531,034 and $160,761 as of December 31, 2019 and 2018, respectively)	[2]	160,761	2,531,034	160,761
Accrued interest payable		46,796	46,796	46,796
Long term accrued interest		1,305,251	1,510,193	1,305,251
Advance from related party	[3]	0	210,000	0
Junior promissory note		926,211	949,434	926,211
Other:
Line of credit guarantee	[4]	$ 1,469,330	1,479,848	1,469,330
S, G & A - Consulting expense [Member]
Other:
Operating expenses - Selling, general and administrative	[2]		368,700	179,166
Debt guarantee fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax	[4]		67,500	56,250
Management Advisory Fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax			$ 975,000	$ 1,072,947
[1]	Consulting Revenue - The Company provided environmental and project consulting to Entsorga West Virginia LLC, an entity that the Company accounted for as an equity investment from March 2017 through December 14, 2018, the date of its control acquisition.
[2]	Management Advisory Fees - The Company provides management advisory services to Gold Medal Holdings, Inc., a subsidiary of GMG.Project Fees - In addition to Management Advisory Fees, the Company also has provided to GMG subsidiaries non-management advisory services related to projects relating to technology and operations.HEBioT Disposal Revenues - Entsorga West Virginia, LLC has a series of agreements with GMG subsidiaries entities that provide for specified fees for each ton of municipal waste delivered to the HEBioT facility.Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International, Inc., a company owned by James Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $200,000 for the term of the License Agreement. Effective October 17, 2018, the agreement was amended to reduce the annual payments to $75,000 and to remove several international locations that the Company does not actively market.
[3]	Disposal costs - A GMG subsidiary has provided logistics and disposal of non-recovered municipal solid waste to the HEBioT facility.Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Minimum lease payments as of December 31, 2019 under these operating leases total $41,926, which are due in 2020.Business Services Fees - A GMG subsidiary provides certain general management and administrative support to the HEBioT facility.Junior Promissory Note - See Note 13.Advance from Related Party - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.
[4]	Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. In connection with the line of credit, the Chief Executive Officer and a Director have provided a guarantee of the line of credit in exchange for a fee representing 4.5% of the debt.

Related Party Transaction - Add

Related Party Transaction - Additional Information (Details)	Dec. 31, 2019USD ($)	Oct. 17, 2018USD ($)	Feb. 02, 2018	Feb. 02, 2016USD ($)	Nov. 30, 2015USD ($)T
Related Party Transaction [Line Items]
2020	$ 146,926
Line of Credit Fee Percentage			4.50%
Amended [Member]
Related Party Transaction [Line Items]
Debt Instrument, Periodic Payment		$ 75,000
Chief Executive Officer
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	13.00%
2020	$ 41,926,000
Mr. Koh [Member]
Related Party Transaction [Line Items]
Debt Instrument, Periodic Payment	$ 200,000
Business Service Agreement [Member]
Related Party Transaction [Line Items]
Term of service agreement				10 years
Term of service agreement renewal				5 years
Consideration payable on service agreement during construction period				$ 72,000
Consideration payable on service agreement on commencement of operation				$ 367,600
Solid Waste Delivery or Disposal Agreement [Member]
Related Party Transaction [Line Items]
Delivery of minimum solid waste in tonnes based on agreement | T					52,000
Maximum amount of Solid waste accepted | T					66,250
Weighted average price per ton on solid waste | T					56.37
Penalty on shortfall of minimum solid waste delivery per ton					$ 20
Penalty on refused minimum solid waste delivery per ton					$ 20
Refuel America LLC [Member]
Related Party Transaction [Line Items]
Percentage of interest acquired	40.00%
Consideration Paid	$ 3,500,000
Additional investment in refuel	$ 2,100,000

Employee 401(k) Savings Plan (D

Employee 401(k) Savings Plan (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Employee 401(k) Savings Plan
Contributions cost for plan	$ 9,339	$ 0

Supplemental Consolidated Sta_3

Supplemental Consolidated Statement of Cash Flows Information (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Sep. 09, 2019	Dec. 14, 2018	Dec. 31, 2017
Changes in operating assets and liabilities:
Accounts receivable	$ (2,049,366)	$ (160,694)
Inventory	(342,447)	(842,944)
Prepaid expenses and other assets	4,083	23,019
Accounts payable	3,265,920	333,633
Accrued interest payable	431,001	446,710
Accrued expenses	(1,463,398)	(982,369)
Deferred revenue	(11,681)	17,225
Customer deposits	37,109	(31,814)
Net change in operating assets and liabilities	(128,779)	(1,197,234)
Supplementary cash flow information:
Interest	2,775,715	484,259
Income taxes	0	0
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
Transfer of inventory to leased equipment	393,795	666,251
Control acquisition of Entsorga West Virginia, LLC with common stock (Note 3)		1,886,330
Common stock issued in settlement of accrued interest	0	915,700
Common stock issued in acquisition of Gold Medal Group, LLC	0	2,250,000
Conversion of notes into common stock	0	9,090,375
Conversion of Series B preferred stock into common stock	0	1,767,371
In-Kind payments by investors for common and preferred stock	0	341,998
Exchange of related party notes payable and advances for Series C preferred stock, warrants and notes payable	0	5,319,777
Accrual of Series A preferred stock dividends	162,584	85,578
Payment of Series A preferred stock dividends in common stock	$ 200,000	$ 0
Conversion of Series A preferred stock into common stock	90,000	533,445	50,000	714,539
Common stock issued in settlement of accounts payable	$ 205,500	$ 0
Reconciliation of Cash and Restricted Cash:
Cash	1,847,526	2,410,709
Restricted cash (short term)	1,133,581	4,195,148
Restricted cash (non-current)	2,555,845	2,520,523
Total cash and restricted cash at the end of the period	$ 5,536,952	$ 9,126,380			$ 901,112

Recent Accounting Standards (De

Recent Accounting Standards (Details)	Jan. 01, 2019
Recent Accounting Standards
Percentage Of Changes In Assets And Liabilities On Adoption Of New Accounting Principle	2.00%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	May 13, 2020	Apr. 27, 2020	Mar. 09, 2020	Apr. 06, 2020	Mar. 18, 2020	Jan. 30, 2020	Dec. 31, 2019	Sep. 09, 2019	Dec. 31, 2018	Dec. 14, 2018
Subsequent Event [Line Items]
Application amount approved under paycheck protection program	$ 421,300
Application amount not yet approved under paycheck protection program	200,000
Advance from related party							$ 210,000		$ 0
Number of designated shares (in shares)							3,179,120		3,159,120
Common Stock, Par or Stated Value Per Share							$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Subsequent events
Subsequent Event [Line Items]
Application amount approved under paycheck protection program	421,300
Application amount not yet approved under paycheck protection program	$ 200,000
Preferred Stock Initial Closing Cost				$ 65,000	$ 1,500,000
Preferred Stock New Series Shares				566	13,045
Common Stock Warrants				7,750	178,597
Subsequent events | Series F Redeemable, Convertible Preferred Stock [Member]
Subsequent Event [Line Items]
Number of designated shares (in shares)			30,090
Par Value Per Share (in dollars per share)			$ 0.0001
Stated Value Per Share (in dollars per share)			$ 115
Preferred Stock, Dividend Rate, Percentage			9.00%
Conversion price (in dollars per share)			2.10%
Period after which the preferred stock can be redeemed			24 months
Trading share price			3.00%
Daily trading volume (in shares)			50,000
Warrants Expiration Period			5 years
Common Stock, Par or Stated Value Per Share			$ 2.30
Subsequent events | Chief Executive Officer
Subsequent Event [Line Items]
Advance from related party						$ 1,050,000
Repayment of related party advances		$ 275,000
Subsequent events | Officer
Subsequent Event [Line Items]
Advance from related party						$ 200,000
Repayment of related party advances		$ 200,000

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 14, 2018	Dec. 31, 2017
Current Assets
Cash	$ 1,847,526	$ 2,410,709
Restricted Cash	1,133,581	4,195,148
Other current assets	2,750,062	969,571
Current Assets	5,731,169	7,575,428
Restricted cash	2,555,845	2,520,523
HEBioT facility and other fixed assets	39,146,331
HEBioT facility under construction, net		33,104,007
Other fixed assets		1,797,915
Operating lease right of use assets	945,047
MBT facility development and license costs	8,049,929	8,475,408
Intangible assets, net and investment in subsidiaries		1,771,316
Goodwill.	58,000	58,000	$ 58,000
Other assets	53,726	13,500
Total Assets	56,540,047	55,316,097
Liabilities, Current [Abstract]
Line of credit	1,479,848	1,469,330
Current portion of WV EDA Bonds	1,390,000
Other current liabilities	8,213,007	5,740,493
Current liabilities	11,082,855	7,209,823
Notes payable and other debts	5,118,125	4,890,322
Accrued interest	1,510,193	1,305,251
Non-current lease liabilities	915,170
WV EDA bonds	29,817,426	31,085,902
Total Liabilities	48,443,769	44,491,298
Redeemable preferred stock	726,553	816,553
Stockholders' equity :
Attributable to parent	2,024,143	3,405,551		$ (11,016,724)
Attributable to non-controlling interests	5,345,582	6,602,695
Stockholders' equity	7,369,725	10,008,246
Total liabilities and stockholders' equity	56,540,047	55,316,097
Consolidation, Eliminations [Member]
Current Assets
Cash	0
Restricted Cash	0
Other current assets	(64,669)
Current Assets	(64,669)
Restricted cash	0
HEBioT facility and other fixed assets	0
Operating lease right of use assets	0
MBT facility development and license costs	0
Intangible assets, net and investment in subsidiaries	(10,864,783)	(5,854,952)
Goodwill.	0
Other assets	0
Total Assets	(10,929,452)	(5,854,952)
Liabilities, Current [Abstract]
Line of credit	0
Current portion of WV EDA Bonds	0
Other current liabilities	(650,894)
Current liabilities	(650,894)
Notes payable and other debts	0
Accrued interest	0
Non-current lease liabilities	0
WV EDA bonds	0
Total Liabilities	(650,894)
Redeemable preferred stock	0
Stockholders' equity :
Attributable to parent	0	(5,854,952)
Attributable to non-controlling interests	(10,278,558)
Stockholders' equity	(10,278,558)	(5,854,952)
Total liabilities and stockholders' equity	(10,929,452)	(5,854,952)
Entsorga West Virginia LLC [Member]
Current Assets
Restricted Cash		4,195,148
Current Assets		4,195,148
Restricted cash		2,520,523
HEBioT facility under construction, net		33,104,007
MBT facility development and license costs		1,890,000
Goodwill.		58,000
Total Assets		41,767,678
Liabilities, Current [Abstract]
Other current liabilities		3,708,410
Current liabilities		3,708,410
WV EDA bonds		31,085,902
Total Liabilities		34,794,312
Stockholders' equity :
Attributable to parent		5,854,952
Attributable to non-controlling interests		1,118,414
Stockholders' equity		6,973,366
Total liabilities and stockholders' equity		41,767,678
Entsorga West Virginia LLC [Member] | Reportable Legal Entities [Member]
Current Assets
Cash	0
Restricted Cash	1,133,581
Other current assets	1,116,821
Current Assets	2,250,402
Restricted cash	2,555,845
HEBioT facility and other fixed assets	37,392,601
Operating lease right of use assets	897,026
MBT facility development and license costs	1,795,500
Intangible assets, net and investment in subsidiaries	0
Goodwill.	58,000
Other assets	0
Total Assets	44,949,374
Liabilities, Current [Abstract]
Line of credit	0
Current portion of WV EDA Bonds	1,390,000
Other current liabilities	6,475,985
Current liabilities	7,865,985
Notes payable and other debts	0
Accrued interest	0
Non-current lease liabilities	915,170
WV EDA bonds	29,817,426
Total Liabilities	38,598,581
Redeemable preferred stock	0
Stockholders' equity :
Attributable to parent	0
Attributable to non-controlling interests	6,350,793
Stockholders' equity	6,350,793
Total liabilities and stockholders' equity	44,949,374
Related Party [Member]
Liabilities, Current [Abstract]
Accrued interest	1,510,193	1,305,251
Parent Company [Member]
Current Assets
Cash		2,410,709
Other current assets		969,571
Current Assets		3,380,280
Other fixed assets		1,797,915
MBT facility development and license costs		6,585,408
Intangible assets, net and investment in subsidiaries		7,626,268
Other assets		13,500
Total Assets		19,403,371
Liabilities, Current [Abstract]
Line of credit		1,469,330
Other current liabilities		2,032,083
Current liabilities		3,501,413
Notes payable and other debts		4,890,322
Accrued interest		1,305,251
Total Liabilities		9,696,986
Redeemable preferred stock		816,553
Stockholders' equity :
Attributable to parent		3,405,551
Attributable to non-controlling interests		5,484,281
Stockholders' equity		8,889,832
Total liabilities and stockholders' equity		$ 19,403,371
Parent Company [Member] | Reportable Legal Entities [Member]
Current Assets
Cash	1,847,526
Restricted Cash	0
Other current assets	1,697,910
Current Assets	3,545,436
Restricted cash	0
HEBioT facility and other fixed assets	1,753,730
Operating lease right of use assets	48,021
MBT facility development and license costs	6,254,429
Intangible assets, net and investment in subsidiaries	10,864,783
Goodwill.	0
Other assets	53,726
Total Assets	22,520,125
Liabilities, Current [Abstract]
Line of credit	1,479,848
Current portion of WV EDA Bonds	0
Other current liabilities	2,387,916
Current liabilities	3,867,764
Notes payable and other debts	5,118,125
Accrued interest	1,510,193
Non-current lease liabilities	0
WV EDA bonds	0
Total Liabilities	10,496,082
Redeemable preferred stock	726,553
Stockholders' equity :
Attributable to parent	2,024,143
Attributable to non-controlling interests	9,273,347
Stockholders' equity	11,297,490
Total liabilities and stockholders' equity	$ 22,520,125

Condensed Consolidating Finan_4

Condensed Consolidating Financial Information - Statement of Operations (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenues	$ 3,359,324	$ 4,219,448	$ 3,359,324	$ 3,359,324
Cost of revenue	1,640,152
Gross profit	1,719,172
Operating Expenses [Abstract]
Selling, general and administrative	6,741,561	7,063,691
Depreciation and amortization	115,038	1,729,478
Total operating expenses	6,856,599	11,754,662	8,496,751
Loss from operations	(5,137,427)	(7,535,214)	(5,137,427)
Other (income) expenses, net	9,609,793	2,744,847	9,609,793
Net loss	(14,747,220)	(10,280,061)	(14,747,220)
Consolidation, Eliminations [Member]
Revenues		0
Operating Expenses [Abstract]
Selling, general and administrative		0
Depreciation and amortization		0
Total operating expenses		0
Loss from operations		0
Other (income) expenses, net		0
Net loss		0
Entsorga West Virginia LLC [Member]
Operating Expenses [Abstract]
Selling, general and administrative	64,237
Total operating expenses	64,237
Loss from operations	(64,237)
Other (income) expenses, net	5,265
Net loss	(69,502)
Entsorga West Virginia LLC [Member] | Reportable Legal Entities [Member]
Revenues		1,111,071
Operating Expenses [Abstract]
Selling, general and administrative		965,874
Depreciation and amortization		1,233,769
Total operating expenses		4,263,782
Loss from operations		(3,152,711)
Other (income) expenses, net		2,056,226
Net loss		(5,208,937)
Parent Company [Member]
Revenues	3,359,324
Cost of revenue	1,640,152
Gross profit	1,719,172
Operating Expenses [Abstract]
Selling, general and administrative	6,677,324
Depreciation and amortization	115,038
Total operating expenses	6,792,362
Loss from operations	(5,073,190)
Other (income) expenses, net	9,604,528
Net loss	$ (14,677,718)
Parent Company [Member] | Reportable Legal Entities [Member]
Revenues		3,108,377
Operating Expenses [Abstract]
Selling, general and administrative		6,097,817
Depreciation and amortization		495,709
Total operating expenses		7,490,880
Loss from operations		(4,382,503)
Other (income) expenses, net		688,621
Net loss		(5,071,124)
HEBioT (related entity)
Cost of revenue		2,064,139	0
HEBioT (related entity) | Consolidation, Eliminations [Member]
Cost of revenue		0
HEBioT (related entity) | Entsorga West Virginia LLC [Member] | Reportable Legal Entities [Member]
Cost of revenue		2,064,139
Rental, service and maintenance [Member]
Cost of revenue		784,291	884,342
Rental, service and maintenance [Member] | Consolidation, Eliminations [Member]
Cost of revenue		0
Rental, service and maintenance [Member] | Entsorga West Virginia LLC [Member] | Reportable Legal Entities [Member]
Cost of revenue		0
Rental, service and maintenance [Member] | Parent Company [Member] | Reportable Legal Entities [Member]
Cost of revenue		784,291
Equipment sales [Member]
Cost of revenue		113,063	$ 402,621
Equipment sales [Member] | Consolidation, Eliminations [Member]
Cost of revenue		0
Equipment sales [Member] | Entsorga West Virginia LLC [Member] | Reportable Legal Entities [Member]
Cost of revenue		0
Equipment sales [Member] | Parent Company [Member] | Reportable Legal Entities [Member]
Cost of revenue		$ 113,063

Condensed Consolidating Finan_5

Condensed Consolidating Financial Information - Statement of Cash Flow (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Cash flows used in operating activities:
Net loss	$ (14,747,220)	$ (10,280,061)	$ (14,747,220)
Non-cash adjustments to reconcile net loss to net cash used in operations	9,900,310	3,274,240
Changes in operating assets and liabilities	(1,197,234)	(128,779)	(1,197,234)
Net cash used in operations	(6,044,144)	(7,134,600)	(6,044,144)
Cash flows used in investing activities:
Cash acquired from control acquisition of Entsorga West Virginia, LLC	6,773,384	0	6,773,384
Construction of HEBioT facility and acquisitions of equipment		(5,111,209)
Other investing activities	(691,216)	(2,231,824)
Net cash used in investing activities	6,082,168	(2,879,385)	6,082,168
Cash flows from financing activities:
Issuances of debt and preferred stock, net of costs incurred	7,378,869
Issuances of debt and equity		6,418,057
Repayments of debt	(2,472,611)	(9,165)
Cash investment in Refuel America, LLC by non-controlling interest	3,500,000
Other	(255,023)
Deferred financing costs incurred		(62,151)	(246,131)
Net cash provided by financing activities	8,151,235	6,346,741	8,151,235
Effect of exchange rate on cash	36,009	77,816	36,009
Cash - beginning of period (restricted and unrestricted)		9,126,380	901,112
Cash - end of period (restricted and unrestricted)	9,126,380	5,536,952	9,126,380
Consolidation, Eliminations [Member]
Cash flows used in operating activities:
Net loss		0
Non-cash adjustments to reconcile net loss to net cash used in operations		0
Changes in operating assets and liabilities		0
Net cash used in operations		0
Cash flows used in investing activities:
Construction of HEBioT facility and acquisitions of equipment		0
Capital contribution to Entsorga West Virginia, LLC	1,000,000	4,586,362
Other investing activities		0
Net cash used in investing activities	1,000,000	4,586,362
Cash flows from financing activities:
Issuances of debt and equity		(4,586,362)
Repayments of debt		0
Capital contribution to Entsorga West Virginia, LLC	(1,000,000)
Deferred financing costs incurred		0
Net cash provided by financing activities	(1,000,000)	(4,586,362)
Effect of exchange rate on cash		0
Cash - beginning of period (restricted and unrestricted)		0
Cash - end of period (restricted and unrestricted)	0	0	0
Entsorga West Virginia LLC [Member]
Cash flows used in operating activities:
Net loss	(69,502)
Changes in operating assets and liabilities	(669,124)
Net cash used in operations	(738,626)
Cash flows used in investing activities:
Cash acquired from control acquisition of Entsorga West Virginia, LLC	6,773,384
Other investing activities	(319,086)
Net cash used in investing activities	6,454,298
Cash flows from financing activities:
Capital contribution to Entsorga West Virginia, LLC	1,000,000
Net cash provided by financing activities	1,000,000
Cash - beginning of period (restricted and unrestricted)		6,715,672
Cash - end of period (restricted and unrestricted)	6,715,672		6,715,672
Entsorga West Virginia LLC [Member] | Reportable Legal Entities [Member]
Cash flows used in operating activities:
Net loss		(5,208,937)
Non-cash adjustments to reconcile net loss to net cash used in operations		1,417,445
Changes in operating assets and liabilities		1,318,897
Net cash used in operations		(2,472,595)
Cash flows used in investing activities:
Construction of HEBioT facility and acquisitions of equipment		(5,077,863)
Capital contribution to Entsorga West Virginia, LLC		0
Other investing activities		0
Net cash used in investing activities		(5,077,863)
Cash flows from financing activities:
Issuances of debt and equity		4,586,362
Repayments of debt		0
Deferred financing costs incurred		(62,151)
Net cash provided by financing activities		4,524,211
Effect of exchange rate on cash		0
Cash - beginning of period (restricted and unrestricted)		6,715,672
Cash - end of period (restricted and unrestricted)	6,715,672	3,689,425	6,715,672
Parent Company [Member]
Cash flows used in operating activities:
Net loss	(14,677,718)
Non-cash adjustments to reconcile net loss to net cash used in operations	9,900,310
Changes in operating assets and liabilities	(528,110)
Net cash used in operations	(5,305,518)
Cash flows used in investing activities:
Capital contribution to Entsorga West Virginia, LLC	(1,000,000)
Other investing activities	(372,130)
Net cash used in investing activities	(1,372,130)
Cash flows from financing activities:
Issuances of debt and preferred stock, net of costs incurred	7,378,869
Repayments of debt	(2,472,611)
Cash investment in Refuel America, LLC by non-controlling interest	3,500,000
Other	(255,023)
Net cash provided by financing activities	8,151,235
Effect of exchange rate on cash	36,009
Cash - beginning of period (restricted and unrestricted)		2,410,708	901,112
Cash - end of period (restricted and unrestricted)	2,410,708		2,410,708
Parent Company [Member] | Reportable Legal Entities [Member]
Cash flows used in operating activities:
Net loss		(5,071,124)
Non-cash adjustments to reconcile net loss to net cash used in operations		1,856,795
Changes in operating assets and liabilities		(1,447,676)
Net cash used in operations		(4,662,005)
Cash flows used in investing activities:
Construction of HEBioT facility and acquisitions of equipment		(33,346)
Capital contribution to Entsorga West Virginia, LLC		(4,586,362)
Other investing activities		(2,231,824)
Net cash used in investing activities		(2,387,884)
Cash flows from financing activities:
Issuances of debt and equity		6,418,057
Repayments of debt		(9,165)
Deferred financing costs incurred		0
Net cash provided by financing activities		6,408,892
Effect of exchange rate on cash		77,816
Cash - beginning of period (restricted and unrestricted)		2,410,708
Cash - end of period (restricted and unrestricted)	$ 2,410,708	$ 1,847,527	$ 2,410,708